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Summary 
Hantaviruses are single stranded (ss) RNA viruses belonging to the family 
Bunyaviridae. Over the past years they attracted more and more attention as “emerging 
viruses”, increasingly gaining relevance as human pathogens. Depending on the 
hantavirus type they cause haemorrhagic fever with renal syndrome (HFRS) or 
hantavirus cardiopulmonary syndrome (HCPS). Both syndromes are associated with 
changes in vascular permeability, acute thrombocytopenia, and defects in platelet 
function. The underlying mechanisms are still poorly understood. Until now hantavirus 
research mostly focused on direct effects of the virus on the endothelial barrier. 
Although hantaviruses infect endothelial cells, no viral cytopathic effect after infection 
was observed. Another hypothesis claims that an uncontrolled antiviral immune 
response causes the vascular leakage (concept of immunopathogenesis). How 
pathogenic hantaviruses trigger the sharp decrease in platelet count and interfere with 
platelet function has not been addressed at all so far.  
This thesis investigates in vitro whether and how hantaviruses target cells of the 
haemostatic system. In particular megakaryocytes (MKs), which generate platelets, and 
platelets themselves. We show that pathogenic Hantaan virus (HTNV), in contrast to 
less pathogenic Tula virus (TULV) and Prospect Hill virus (PHV), infects 
megakaryocytic cells. Intriguingly, after induction of differentiation megakaryocytic 
cells switch from low-level to high-level HTNV production without reduction in cell 
survival or alteration in differentiation. Thus, there is no direct viral pathogenic effect 
on megakaryocytic cells as previously observed for endothelial cells. Furthermore, this 
study demonstrates that HTNV interacts with human platelets, resulting in 
downregulation of essential adhesion markers, which are important for platelet 
aggregation and signalling. Finally, the concept of hantavirus-associated 
immunopathogenesis is further corroborated by showing that HTNV activates 
lymphocytes and triggers differentiation of monocytes towards the 
dendritic/macrophage cell phenotype.  
Unfortunately, analysis of hantavirus-induced immunopathogenesis is hampered 
by the fact that no suitable animal model is available so far and normal laboratory 
mouse strains are not susceptible to hantavirus infection. In the future, we will use 
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humanized mice that permit long term human megakaryopoiesis and human immune 
responses to test the concept of hantavirus-induced immunopathogenesis in vivo. 
 
Keywords: hantaviruses, megakaryocytes, platelets, immunopathogenesis 
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Zusammenfassung 
Hantaviren sind einzelsträngige RNA-Viren, die zur Familie der Bunyaviridae gehören. 
In den letzten Jahren haben sie immer mehr Aufmerksamkeit als “emerging viruses” auf 
sich gezogen, welche zunehmend Relevanz als humanpathogene Erreger gewinnen. Sie 
verursachen, abhängig vom Hantavirustyp, zwei verschiedene Krankheitsbilder: das 
hämorrhagische Fieber mit renalem Syndrom (HFRS) und das kardiopulmonale 
Syndrom (HCPS). Beide Syndrome sind mit Veränderungen in der vaskulären 
Permeabilität, akutem Abfall der Blutplättchen (Thrombozytopenie) und 
Koagulationsdefekten verbunden. Die zugrundeliegenden Mechanismen sind noch 
immer kaum verstanden. Bis jetzt fokussierte sich die Forschung auf einen direkten 
Effekt des Virus auf die endotheliale Barriere. Hantaviren infizieren zwar 
Endothelzellen, bisher aber konnte kein zytopathischer Effekt nachgewiesen werden. 
Eine andere Hypothese besagt, dass eine unkontrollierte Immunantwort die endotheliale 
Barriere zerstört und so Hämorrhagien hervorruft (Konzept der Immunopathogenese). 
Auf welche Weise pathogene Hantaviren die akute Thrombozytopenie und den 
Funktionsverlust der Blutplättchen auslösen, ist bisher noch gar nicht untersucht 
worden. 
Diese Doktorarbeit untersucht in vitro, ob und auf welche Weise Hantaviren mit 
Zellen des hämostatischen Systems interagieren. Zu diesen gehören insbesondere 
Megakaryozyten, die Thrombozyten generieren und die Thrombozyten selbst. Wir 
zeigen, dass das pathogene Hantaan Virus (HTNV), im Gegensatz zu dem weniger 
pathogenen Tula Virus (TULV) und Prospect Hill Virus (PHV), megakaryozytäre Zellen 
infiziert. Interessanterweise erhöht sich nach Induktion der Differenzierung in den 
infizierten megakaryozytären Zellen die Virusrepliaktion drastisch. Das Überleben der 
Zellen und der Verlauf der Differenzierung wird dadurch jedoch nicht beeinflusst. 
Ähnlich, wie bereits früher für Endothelzellen gezeigt, haben demnach pathogene 
Hantaviren keinen direkten zytopathischen Effekt auf Megakaryozyten. Weiterhin 
verdeutlicht die vorliegende Doktorarbeit, dass HTNV mit humanen Thrombozyten 
interagiert. Dies resultiert in einer Herunterregulation von essentiellen 
Oberflächenmarkern, die wichtig für die Aggregation und das Signalling sind. 
Schließlich wird das Konzept der Hantavirus-assoziierten Immunopathogenese durch 
Ergebnisse unterstützt, die zeigen, dass HTNV Lymphozyten aktiviert und zur 
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Differenzierung von Monozyten in Richtung des Phänotyps von Dendritischen 
Zellen/Makrophagen führt.  
Leider steht noch kein Tiermodell für Hantavirus-Infektionen zur Verfügung, da 
normale Labormäuse nicht mit Hantaviren infizierbar sind. Deshalb werden wir in 
Zukunft humanisierte Mäuse etablieren, welche humane Megakaryozyten und ein 
humanes Immunsystem generieren, um das Konzept der Hantavirus-induzierten 
Immunpathogenese in vivo zu testen.  
 
Schlagwörter: Hantaviren, Megakaryozyten, Thrombozyten, Immunopathogenese  
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Abbreviations 
aa amino acid(s) 
APC antigen presenting cell 
APS ammonium persulfate  
BCCV  Black Canal Creek virus 
BFU burst-forming unit 
BME  basal medium with Earls’s salt 
BSA bovine serum albumin 
BSL biosafety level 
CaCl2 calcium chloride 
CD cluster of differentiation 
CDC Centers of Disease Control and Prevention  
CFU colony-forming unit 
CTL cytotoxic T-cell 
DAF decay-accelerating factor 
DC dendritic cell 
DMSO Dimethylsulfoxid 
DNA deoxyribonucleic acid 
DOBV Dobrava virus 
ds double stranded 
dUTP 2-Deoxyuridine 5’-Triphosphate 
EBOV ebola virus 
ECM extracellular matrix 
EDTA ethylene-diamine-tetra-acetic acid 
ER endoplasmic reticulum 
ERGIC endoplasmic reticulum golgi intermediate compartment 
FACS fluorescence associated cell sorting 
F-actin filamentous actin 
FCS foetal calf serum 
FFU focus forming units 
FITC fluorescein isothiocyanate 
Abbreviations 
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G1 glycoprotein 1 
G2 glycoprotein 2 
GM-CSF   granulocyte-macrophage colony-stimulating factor 
GP glycoprotein 
GPI glycosylphosphatidylinositol  
h hours 
HBSS hanks’ balanced salt solution 
HCl  hydrochloric acid 
HCPS   hantavirus cardiopulmonary syndrome 
HEK293 human embryonic kidney cells  
HEPES   N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic acid 
HFRS   hemorrhagic fever with renal syndrome 
HIV human immunodeficiency virus 
HLA human leukocyte antigen 
HSC haematopoietic stem cell 
HSV1 herpes simplex virus type 1 
HTNV Hantaan virus 
HUVEC   human umbilical vein endothelial cells 
ICAM- 1 intercellular adhesion molecule-1 
IFN interferon 
Ig immunoglobolin 
IL interleukin 
ISG interferon stimulated gene 
JAK  janus protein tyrosine kinase 
L liter 
LFA-1 leukocyte function associated antigen 
L-segment large genome segment 
MAC-1 macrophage-1 antigen 
MAPK mitogen-activated protein kinases 
MFI  mean fluorescence intensity 
min minutes 
Abbreviations 
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MK megakaryocyte 
MOI   multiplicity of infection 
M-segement medium genome segment 
N nucleocapsid 
NaCl   sodium chloride 
NaN3  sodium azide 
NE  nephropathia epidemica 
N-protein   nucleocapsid-protein 
NYV New York virus 
OD  optical density 
PAMP  pathogen-associated molecular patterns 
PBMC  peripheral blood mononuclear cells 
PBS phosphat buffered saline 
pc positive control 
PCR polymerase chain reaction 
PE  phycoerythrin 
PGE1 Prostaglandin 1 
PHV Prospect hill virus 
PI propidiumiodide 
pi post infection 
PKR  protein kinase R 
PMA 4-β−phorbol-12-myristate-13-acetate 
prp platelet rich plasma 
PRR pattern recognition receptors 
PSI plexin-semaphorin-integrin 
PUUV Puumala virus 
RdRp RNA dependent RNA polymerase 
ReoV Reovirus 
RGD arginine-glycine-aspartic acid 
RIG-I  retinoic acid inducible gene I 
RNA  ribonucleic acid 
Abbreviations 
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rpm  revolutions per minute 
RPMI 1640  roswell park memorial institute medium 
SANGV  Sangassou virus 
SD standard deviation 
SDS sodium dodecyl sulphate 
SEOV Seoul virus  
SNV Sin Nombre virus 
ss single stranded 
S-segment  small genome segment 
STAT  signal transducer of activation and transcription 
SUMO-1 ubiquitin-like modifier-1 
TNF tumor necrosis factor  
TPO thrombopoeitin 
Tris-HCl  tris-(hydroxymethyl)-aminomethan 
TULV Tula virus 
TUNEL  
 
terminal-desoxynucleotidyl-transferase-mediated dUTP 
nick end labeling 
TYK tyrosine kinase  
U units 
vRNA viral RNA 
VSV vesicular stomatitis virus 
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1 Introduction 
1.1 Hantaviruses 
1.1.1 Hantaviruses as emerging pathogens 
A complex interplay of pathogen, host and environmental determinants defines the 
spread of an infection. Due to increasing globalisation some infections gain more and 
more significance for public health. These “emerging infections” are pushed forward by 
socio-economic, environmental, ecological, and genetic factors (Jones et al., 2008; 
Klempa, 2009; Morens et al., 2008). 
The World Health Organisation defines emerging zoonoses as “a zoonosis that is 
newly recognized or newly evolved, or that has occurred previously but shows an 
increase in incidence or expansion in geographical, host or vector range” (WHO, 2009). 
Thus hantaviruses belong to zoonotic emerging viruses because of the perpetual 
discovery of new hantaviruses in many different parts of the world (Europe, Asia, 
America, Africa) and the cyclic reemergence since detection (Schonrich et al., 2008). 
Hantaviruses are found worldwide, but for many regions knowledge about circulating 
hantaviruses is still limited. Diseases caused are haemorrhagic fever with renal 
syndrome (HFRS) or hantavirus cardiopulmonary syndrome (HCPS). In Germany 
hantavirus-infections belong to the notifiable diseases since 2001. From that time on 
every year a few hundred cases were observed until 2007 when 1687 cases of Puumala 
virus (PUUV) infections occurred (figure 1). PUUV causes a relatively mild form of 
HFRS, the nephropathia epidemica (NE). In contrast to the epidemiological situation in 
previous years, where most cases occurred in metropolitan areas, the 2007 outbreak was 
predominantly restricted to rural areas in western and southern Germany (Hofmann et 
al., 2008). In the same year trapping and analysis of bank voles (Myodes glareolus) 
revealed a high number of PUUV-infected reservoir hosts (Kruger, 2008).  
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Figure 1: Diagram indicating hantavirus infections in Germany, 2001-2009.  
On the y-axis cases/year, the x-axis time in years is indicated. Data from www.rki.de. 
 
1.1.2 History 
Hantavirus-associated diseases are known for hundreds of years. The first description 
can be found in chinese literature of the 10th century, but worldwide attention was 
attracted for the first time during the Korean War (1951-1953): about 3000 UN soldiers 
suffered from the “korean haemorrhagic fever” with clinical manifestations like fever, 
abdominal back pain, myalgia, chills, haemorrhages, shock and renal failure. The 
mortality rate was up to 15% (Smadel, 1953). The causative agent of the disease 
remained obscure until 1978, when Ho Wang Lee and co-workers successfully isolated 
the first hantavirus from lung tissue of its natural reservoir host, Apodemus agrarius 
(striped field mouse) (Lee et al., 1978). Finally, in 1981, Hantaan virus (HTNV), named 
after the Korean river Hantaan, was propagated in cell culture (French et al., 1981). 
During the last years many new hantavirus strains were detected. Presently 22 
hantavirus species are accepted by the International Committee of Virus Taxonomy 
(Nichol et al., 2005). Depending on their geographical distribution hantaviruses are 
divided into Old World hantaviruses, circulating in Asia and Europe and New World 
hantaviruses, circulating in the Americas. Old World hantaviruses cause the HFRS and 
the milder NE, whereas New World hantaviruses are responsible for the HCPS. A 
selection of some important hantaviruses is listed in table 1. According to the Centers of 
Disease Control and Prevention (CDC) hantaviruses are potential bioweapons of 
 2 
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category C, because they are emerging pathogens that could be engineered for mass 
spread (CDC, 2009). 
 
Table 1: Selection of some important hantaviruses circulating in Europe, Asia or the Americas and 
their respective reservoir host, distribution, associated disease and case fatality  
Virus species Reservoir host Geographical 
distribution 
 
Human disease Case fatality 
Hantaan virus 
(HTNV) 
 
Apodemus 
agrarius 
Asia HFRS up to 15% 
Dobrava-Belgrade 
virus (DOBV) 
 
Apodemus 
flavicollis and 
other Apodemus 
spp. 
Europe HFRS 1-12% 
Sangassou virus 
(SANGV) 
 
Hylomyscus 
alleni 
West-Africa HFRS ? ? 
Puumala virus 
(PUUV) 
 
Myodes 
glareolus 
Europe HFRS/NE < 1% 
Tula virus 
(TULV) 
 
Microtus arvalis 
and other 
Microtus spp. 
Europe HFRS ? 1 case 
described 
Prospect Hill virus 
(PHV) 
 
Microtus 
pennsylvanicus 
USA - - 
Sin Nombre virus 
(SNV) 
Peromyscus 
maniculatus 
North America HCPS 35% 
HFRS: haemorrhagic fever with renal syndrome, NE: nephropathia epidemica, HCPS: Hantavirus 
pulmonary syndrome, 
 
1.1.3 Structure, genome and replication 
Hantaviruses belong to the family of the Bunyaviridae, and appear as spherical, 
enveloped viruses with a diameter of 78-120 nm (Goldsmith et al., 1995). They have a 
single-stranded tripartite RNA genome of negative polarity encapsidated by the viral 
nucleoprotein (Obijeski et al., 1976). The small (S) segment codes for the 
nucleoprotein, the medium (M) segment codes for the two glycoproteins G1 and G2 
(also called Gn and Gc) that are cleaved cotranslationally, and the large (L) segment 
codes for the RNA dependent RNA polymerase (RdRp) which has further functions as 
replicase, transcriptase and endonuclease (Schmaljohn & Hjelle, 1997). Among 
hantaviruses the 3’ and 5’ termini of the RNA segments are highly conserved and 
complementary, thereby forming panhandle structures, presumably used for initiation of 
Introduction 
transcription and replication (Hewlett et al., 1977). A schematic description of a 
hantavirus virion is shown in figure 2. 
 
 
Figure 2: Schematic description of a hantavirus particle.  
A lipid envelope carrying the two glycoproteins G1 and G2 surrounds three nucleocapsids consisting of 
distinct RNA segments; the S-segment, the M-segment and the L-segment, which form a complex with 
the viral N-protein and are associated with the virus-encoded RNA polymerase. 
 
Hantaviruses enter cells via different receptors. For pathogenic hantaviruses 
αIIbβ3 and αvβ3, for non-pathogenic hantaviruses α5β1 were identified as receptors 
(Gavrilovskaya et al., 1999; Gavrilovskaya et al., 1998). Recently, decay-accelerating 
factor (DAF/CD55), a glycosylphosphatidylinositol (GPI)-anchored protein and the 
glycoprotein globular head domain of complement component C1q (gC1qR) were 
recognized to mediate infection with HTNV (Choi et al., 2008; Krautkramer & Zeier, 
2008). 
After first contact between cellular receptors and viral glycoproteins, clathrin-
dependent endocytosis takes place (Jin et al., 2002). After uncoating of the virus in the 
cytoplasma, transcription of negative sense vRNA to mRNA is started by the RdRp. 
Primers for initiation of transcription are 5’-caps cleaved from cellular mRNAs (cap 
snatching) (Garcin et al., 1995). Translation already begins when transcription is still in 
process. The mRNA of L- and S-segment is translated on free ribosomes in the 
cytoplasm (Ravkov & Compans, 2001), whereas M-segment mRNA is translated on 
endoplasmatic reticulum bound ribosomes. After cotranslational cleavage, glycoproteins 
are transported to the Golgi-apparatus for subsequent glycosylation and formation of 
heterodimers (Lober et al., 2001; Ruusala et al., 1992). Localisations of further 
maturation steps still have to be clarified. Most members of the family Bunyaviridae 
such as HTNV are known to bud into the Golgi-cisternae for maturation (Elliott, 1990). 
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However, the New World hantaviruses Sin Nombre (SNV) and Black Canal Creek 
(BCCV) were detected to mature at the cell surface (Ravkov et al., 1997; Ravkov et al., 
1998). Eventually, the cell releases mature viral particles via exocytosis. 
 
1.1.4 Reservoir hosts 
Natural reservoir hosts for hantaviruses are rodents and shrews. Since hantaviruses are 
restricted to their natural reservoir host, a long time of co-evolution is assumed (Hughes 
& Friedman, 2000; Ulrich et al., 2002). Nevertheless phylogenetic research showed that 
for individual viruses several rodent hosts and vice versa (several viruses in one host) 
might be possible (Muranyi et al., 2005). It seems that the virus has found new ways for 
entering novel hosts and thereby disperses more efficiently, but although spillover can 
occur, geographic distribution of the virus strain is determined by habitats of the host.  
Natural occurring reassortment is a rare event, but has been shown in several 
cases; between different Sin Nombre genetic variants (Henderson et al., 1995), between 
different Convict Creek variants (Li et al., 1995), between PUUV variants (Razzauti et 
al., 2009), between HTNV and Seoul virus (SEOV) (Zou et al., 2008) as well as 
between DOBV-Aa and DOBV-Af (Klempa et al., 2003). Also in vitro reassortment was 
demonstrated, e.g. between Sin Nombre and Black Creek Canal virus (Rodriguez et al., 
1998) and between Dobrava Slo/Af and Dobrava Sk/Aa (Kirsanovs et al., unpublished 
data).  
Transmission between rodents takes place horizontally, mainly through aggressive 
behaviour (e.g. bites) (Botten et al., 2002; Lee et al., 1981). In the beginning of 
hantavirus research it was believed that viruses do not cause any symptoms in their 
reservoir host (Childs et al., 1989), but since 1996 some evidence has been provided 
that rodents infected with New York virus (NYV) or SNV show pulmonary oedema and 
periportal hepatitis (Lyubsky et al., 1996; Netski et al., 1999). Transmission to other 
animal species like moose, cat or dog, can occur as spill over but no persistent infection 
has been described in these animals (Muranyi et al., 2005).  
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1.2 Hantavirus-associated clinical syndromes in humans  
1.2.1 Clinical course 
Transmission to humans occurs via the respiratory route by inhalation of aerosols from 
rodent saliva, urine and faeces. Hence, the respiratory tract is the first site of infection 
(McCaughey & Hart, 2000). Nevertheless, transmission by bites has been observed 
(Douron et al., 1984). Humans are dead end hosts for hantaviruses as no transmission to 
further hosts occurs. Solely for Andes virus person-to-person transmission has been 
reported (Enria et al., 1996; Padula et al., 1998), a controversial issue discussed among 
hantavirus researchers. Although hantaviruses cause no lethal symptoms in their natural 
hosts they can induce severe disease in humans. Case fatality rates are up to 15% (Lee, 
1989; Lee et al., 1978) for HFRS and 0.15% for NE (Brummer-Korvenkontio et al., 
1980; Mustonen et al., 1998). The typical symptom observed is renal failure. 
Cardiopulmonary syndrome, caused by new world hantaviruses, is associated with a 
lethality rate of 30-50% (CDC, 2008; Nichol et al., 1993). HCPS is characterized by 
pulmonary oedema and respiratory distress. Although three different syndromes are 
observed, boundaries between symptoms are flowing and some common features may 
be shared. In the following chapter HFRS an NE will be explained in more detail. 
 
1.2.2 HFRS and NE 
First symptoms are observed approximately 2-4 weeks after infection. The clinical 
course is divided into fives stages: (1) febrile phase, (2) hypotensive phase, (3) oliguric 
phase, (4) polyuric phase and (5) convalescent phase. The first phase of about 3-5 days 
is characterized by chills, myalgia, headache, vomiting and blurred vision (Schonrich et 
al., 2008). Platelet count decreases (thrombocytopenia) with platelet count below 
150.000 x 109 platelets/L and platelet function may be defective (Lee, 1987). Along with 
this decrease haemorrhages like petechiae, bleedings of mucosa, hematuria and epistaxis 
can occur. In addition disseminated intravascular coagulation is possible (Lee et al., 
1983). The hypotensive phase lasts few hours to 2 days. Typical symptoms are 
hypotension, shock and leukocytosis. Renal function is derogated. This can result in 
proteinuria, oliguria (or anuria) and abnormal urinary sediment in the following oliguric 
phase (2-7 days). During the following polyuric phase kidney function returns to a 
normal level but polyuria still creates problems with fluid and electrolyte management 
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(Peters et al., 1999). Recovery during the convalescent phase can persist for several 
months. NE is a mild variant of HFRS with symptoms similar to those of HFRS but less 
severe (Muranyi et al., 2005; Schonrich et al., 2008). So far no antiviral therapy and no 
WHO-approved vaccine exist. Thus treatment of patients is only supportive. (Maes et 
al., 2009).  
 
1.3 Hantavirus-induced pathogenesis in humans: direct viral effects?  
Many aspects of hantavirus-induced pathogenesis are unclear. Direct and indirect viral 
effects are discussed. Hantaviruses infect endothelial cells, which build a selective 
barrier between the vessel lumen and surrounding tissue, but so far virus-induced 
cytopathic effects were not detected in endothelial cell cultures although hantavirus-
induced cell death of some cell lines has been reported. Moreover, it has been suggested 
that interaction of pathogenic hantaviruses and integrins could lead to disruption of 
important endothelial cell functions leading to haemorrhages (Gavrilovskaya et al., 
1999; Gavrilovskaya et al., 2002; Gavrilovskaya et al., 1998). Alternatively, the virus 
could cause symptoms indirectly by inducing a massive and uncontrolled immune 
response, which eliminates the virus at the cost of considerable collateral damage, a 
process called immunopathogenesis (Khaiboullina & St Jeor, 2002).  
 
1.3.1 Cell death  
The phenomenon of "cell death" can be subdivided into three different categories: 
apoptosis (type I), autophagy (type II), and necrosis (type III). Boundaries are floating 
and especially morphologies of type I and type II overlap (Lockshin & Zakeri, 2004). 
Apoptosis is the programmed cell death, a suicide program of the cell. It is part of 
the cellular metabolism. This implies that the whole process is under stringent control. 
During apoptosis shrinkage of cells, condensation of chromatin, nuclear fragmentation 
and membrane blebbing is observed. Apoptosis can be driven by intrinsic (the cell itself 
induces apoptosis) or extrinsic (apoptosis is induced by outer stimuli) signals. 
Autophagy is a major pathway for the degradation of long-lived proteins and cellular 
organelles via lysosomal machinery. Vacuolisation, degradation, recycling of 
cytoplasmic contents and little chromatin condensation are observed. It is assumed that 
autophagy mediates apoptosis (Hsieh et al., 2009; Lockshin & Zakeri, 2004). Necrosis 
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is a passive, degenerative cell death. It is characterized by complete disintegration of 
organelles and results in uncontrolled lysis of the cell and inflammatory reactions 
(Galluzzi et al., 2007). After viral infection all kinds of cell death are possible: 
apoptosis/autophagy driven by the cell for clearance of the virus and necrosis as an 
uncontrolled inflammatory reaction due to viral replication.  
Cell death after infection with hantaviruses is a controversially discussed topic. 
Apoptosis was detected in VeroE6 cells after infection with HTNV and PHV (Kang et 
al., 1999). In human embryonic kidney cells (HEK293) a cytopathic effect was 
observed 3-4 days after infection with different pathogenic hantaviruses (Markotic et 
al., 2003). In addition triggering of proapoptotic death was observed after infection of 
VeroE6 cells with Tula virus (Li et al., 2005). Other studies revealed different results. 
Pensiero et al. could not show cytopathic effects after infection of endothelial cells with 
HTNV (Pensiero et al., 1992) and no apoptosis was detected after infection of primary 
dendritic cells with HTNV (Raftery et al., 2002). 
 
1.4 Integrins  
Integrins enclose a family of highly conserved proteins found in multifarious species, 
ranging from sponges to mammals. They are transmembrane receptor proteins that 
consist of two non-covalently bound glycoprotein subunits. As integrins are always 
composed of one α and one β subunit, they are called heterodimeric receptors. 
Currently, in mammals 19 α and 8 β subunits are known to form 25 distinct integrin-
receptors (Humphries, 2000; Hynes, 1987). Many integrins harbour alternative splice 
variants, thus increasing their variety on protein level. For example, for β1-integrin five 
different isoforms are known (β1A, β1B, β1C, β1C2, β1D) (Fornaro & Languino, 1997; 
Svineng et al., 1998). Variants are expressed on different cell types and may differ in 
their function (Flier & Sonnenberg, 2001).  
Integrins are composed of a large extracellular domain and a short cytoplasmic 
tail. Both are involved in ligand recognition. That implies integrins are able to intercede 
bidirectional signalling: “outside-in” as well as “inside-out” (Ginsberg et al., 1992; 
Shattil et al., 1998). Most integrins bind more than one ligand and most ligands bind 
more than one integrin (Hynes, 1992). That makes the receptors potent mediators in 
cell-cell interactions. In addition most integrins are not constitutively active: they exist 
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in three different conformations, inactive (low affinity), active (high affinity) and ligand 
occupied. By different conformations integrin function is regulated (Askari et al., 2009). 
Integrins are participants in versatile biological processes. Their primary function 
is mediating interaction of cells with the extracellular matrix (ECM). For adhesion 
integrins initiate remodelling of the cytoskeleton forming specialized structures. These 
structures, called focal adhesions, are bunched actin filaments connected to integrins 
(Hynes & Lander, 1992; Flier & Sonnenberg, 2001). Furthermore, integrins are 
important for cell-cell contacts, signal transduction, proliferation, apoptosis, 
differentiation, migration, the immune response, haemostasis and play a key role in 
many human diseases, e.g. Glanzmann’s disease, a bleeding disorder (Giancotti & 
Ruoslahti, 1999; Hynes, 2002; Nurden, 2006; Schwartz et al., 1995; Flier & 
Sonnenberg, 2001). 
 
1.4.1 Hantaviruses and integrins 
As mentioned above hantaviruses use integrins to enter the cell. Raymond et al. showed 
that HTNV only binds to the inactive form of β3 integrin and that binding to the 
receptor is independent of the presence of the RGD (arginine-glycine-aspartic acid) 
peptide motif, a general binding motif of integrins, but dependent on PSI (plexin-
semaphorin-integrin) domain that is found at the apex of inactive αvβ3 (Raymond et al., 
2005). Moreover, it was shown that Andes virus uses the PSI domain of β3 for entry 
(Matthys et al., 2009). No motif-dependent use of β1 by apathogenic hantaviruses has 
been shown so far. β1 integrin can be found on nearly all cell types. Expression of β3 is 
more differentiated. It is expressed together with αIIb as a receptor on platelets and 
megakaryocytes, together with αv it is found on a wide variety of cells such as 
endothelial cells, smooth muscle cells, mast cells and monocytes. 
 
1.5 Haematopoiesis 
Haematopoiesis is the formation of cellular blood components. This capacity for 
renewal of the haematopoietic components relies on haematopoietic stem cells (HSCs), 
which possess a high proliferative potential. The haematopoietic system provides a 
constant supply of all blood cells and very distinct functions can be attributed to at least 
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10 different cell types present in the peripheral blood. Among these are megakaryocytes 
and platelets, playing a crucial role in haemostasis. A striking, and so far unresolved, 
feature of hantavirus-associated pathogenesis is the acute loss of platelets, which are 
derived from mature megakaryocytes. The cause for hantavirus-associated 
thrombocytopenia can have two reasons: 1) decreased production of platelets due to 
defects in the process of platelet formation, the megakaryopoiesis and thrombopoiesis or 
2) destruction of platelets in peripheral blood.  
 
1.5.1 Megakaryopoiesis and thrombopoiesis 
Megakaryocytes, the precursors of platelets, are, with a diameter of 40-50 μm, the 
biggest cells in the bone marrow. They originate from pluripotent haematopoietic stem 
cells, which mature and further differentiate to finally release platelets.  
Megakaryopoiesis, the formation of megakaryocytes, is a multiple-stage 
development. Pluripotent haematopoietic stem cells, that carry the stem cell surface 
marker CD34, differentiate to the primitive MK progenitor cells, called burst-forming 
unit-MK (BFU-MK). Out of these cells the more differentiated colony forming unit MK 
(CFU-MK) are formed. These cells hold a high proliferation activity (Briddell et al., 
1989). In the next step promegakaryoblasts followed by megakaryoblasts develop. 
Approximately at this point in time cell division is arrested and cells undergo 
endoreplication. Thus cell size is enlarged, DNA content is increased and a cell with a 
multilobular nucleus and DNA content of 16-64n is generated (Odell et al., 1976). 
Megakaryocytes with lower DNA content have less thrombopoietic potential since MK 
ploidy is connected to functional gene amplification (Odell & Jackson, 1968; Raslova et 
al., 2003). It is assumed that CD34 expression is downregulated over time and 
expression of integrins αIIb (CD41), β3 (CD61) (forming receptor αIIbβ3) and CD51 is 
increased (Debili et al., 1992). Expression of CD41 is a marker for onset of 
haematopoiesis, but only expression of the receptor αIIbβ3 results in commitment 
towards the megakaryocytic lineage (Emambokus & Frampton, 2003; Mikkola et al., 
2003). Subsequently, additional typical markers can be identified on the surface of the 
cells, e.g. CD42 (a multimer combining the glycoproteins CD42a (GPIX), CD42b 
(GPIbα), CD42c (GPIbβ) and CD42d (GPV)). During development cellular equipment 
has changed significantly and all typical megakaryocyte- and platelet-proteins have 
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been synthesized. The next step is the terminal maturation into proplatelet-forming 
megakaryocytes. These cells, juxtaposed to the blood vessels, form long cytoplasmic 
protrusions; designated proplatelets. The proplatelets protrude across the endothelial 
barrier into the blood stream, where mature platelets are released by cytoplasmic 
constriction at the very ends of the extensions (Italiano et al., 1999; Junt et al., 2007; 
Radley & Scurfield, 1980). Main regulator of the development processes is 
thrombopoietin (TPO), a glycoprotein hormone (Kaushansky, 1995). Altogether, the 
interaction of many cytokines, receptors and matrix proteins leads to the formation of 
the mature megakaryocyte and ultimately platelets. Figure 3 depicts a summary of 
megakaryopoiesis and thrombopoiesis. 
 
 
Figure 3: Scheme of megakaryopoiesis and thrombopoiesis.  
Haematopoietic stem cells differentiate, via several steps of proliferation and maturation into the mature 
megakaryocyte. Megakaryocytes form extension of the cytoplasma, designated proplatelets. At the ends 
of the extensions platelets are produced by cytoplasmic constriction. During megakaryopoiesis CD34 is 
downregulated and megakaryocyte/platelet proteins like CD41, CD61, CD51 and CD42 are upregulated. 
 
1.5.2 Platelets 
The cellular components of coagulation are platelets. In 1882 Giulio Bizzozero 
discovered platelets as a component of the blood involved in coagulation after vascular 
injury (Bizzozero, 1882). Since this finding a great deal of research has been done in the 
platelet field.  
Platelets are anucleate, discoid shaped cells (≈ 0.5 – 3.0 µm). Out of one single 
megakaryocyte approximately 1000 functional platelets can be produced. Mitochondria 
 11
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as well as enzymes of glycolysis and pentose-phosphate-pathway ensure survival of 
platelets. After a lifespan of 7-10 days they are degraded in liver and spleen. The 
physiological cell count in human blood is 150-400 x 109/L. 
Next to mitochondrial DNA, platelets contain low amounts of mRNA that is used 
for active protein biosynthesis (Kieffer et al., 1987). Platelets possess various 
molecules, which function as receptors for agonists and adhesion. In addition, platelets 
imply three different kinds of granules: δ−granules, α-granules and λ−granules. The 
δ−granules, the smallest granules, contain nucleotides, amines, and bivalent cations. The 
α granules store platelet specific proteins (e.g. platelet factor 4) and plasma proteins 
(e.g. thrombospondin) that are involved in haemostasis, inflammation, healing and 
adhesion (Niewiarowski et al., 1994). The λ−granules contain digestive enzymes, acid 
proteases like cathepsin D and E and glycohydrolases e.g. heparinase (Rendu & 
Brohard-Bohn, 2001).  
Next to their fundamental role in haemostasis platelets are also important immune 
cells. They contain various bioactive compounds, which are released upon activation 
and are able to phagocytose immuncomplexes and viral particles (Loffler et al., 1997). 
 
1.5.3 Haemostasis 
Haemostasis is the sum of all physiological processes that stop bleedings. It is an 
essential process to sustain the integrity of the vascular system after injury. Thereby loss 
of blood is minimized. The major participants of this process are platelets, the 
endothelium and the blood-plasma with its various coagulation factors.  
Haemostasis is divided into two phases: primary and secondary haemostasis. 
During primary haemostasis vasoconstriction (the narrowing of the blood vessel), 
adhesion and activation of platelets takes place at the site of vascular injury. In 
secondary haemostasis the already formed clot is sustained by addition of fibrin (Teller 
& White, 2009). Integrins and their ligands, important for adhesion and aggregation, 
play a key role in haemostasis (Ni & Freedman, 2003). As soon as any member of the 
processes mentioned above is defect, haemostasis can be disturbed and haemorrhages 
develop. 
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1.6 Immune mechanisms of hantavirus-associated pathogenesis 
1.6.1 The immune system 
The immune response is subdivided into two parts: innate and adaptive. The innate 
immune response is activated immediately after infection by the pathogen in a non-
specific manner. It is the first barrier for the pathogen to overcome. The innate immune 
response relies upon germline-encoded conserved receptors (pattern recognition 
receptor (PRR)) recognising conserved structural moieties on pathogens (pathogen 
associated molecular patterns (PAMPS)). Cells of this first barrier are 
monocytes/macrophages and neutrophils. These cells are able to phagocytose the 
invaded microorganisms and induce further defence mechanisms. Innate immunity is 
able to discriminate between self and non-self efficiently, but no long lasting protection 
is developed (Alberts et al., 2002; Janeway et al., 2002).  
When a pathogen manages to survive the attack by the innate immune system the 
adaptive immune response is induced. The adaptive immune system reacts in a specific 
way and is characterized by adaptation of the cells to the foreign antigen. It is comprised 
of antigen presenting cells (APC), like dendritic cells (DC), of T-lymphocytes 
(responsible for the cellular response), and of B-lymphocytes (important for humoral 
response). Through clonal expansion highly specific immune cells are generated that 
eliminate the pathogen. Additionally, memory cells are produced that prevent future 
infections with the same microbe (Alberts et al., 2002; Janeway et al., 2002).  
 
1.6.2 Hantavirus-induced immune response 
The immune system reacts already four hours after hantavirus infection (Prescott et al., 
2005). Dependent on virus pathogenicity different amounts of interferon stimulated 
genes (ISGs) are upregulated. It was shown that one day after infection with non-
pathogenic PHV expression of ISGs is strongly induced in endothelial cells whereas 
pathogenic HTNV and New York-1 virus (NY-1V) stimulate expression of ISGs not 
prior to four days post infection (Geimonen et al., 2002). Furthermore, retinoic acid 
inducible gene I (RIG-I) a cytoplasmic receptor, that recognizes blunt ended or 5’-
overhang ds (double stranded) RNA ends and uncapped ssRNA 5’-triphosphate ends 
(Yoneyama et al., 2008) has been analysed in the context of hantavirus infection. Lee et 
al. (unpublished data) showed that RIG-I replication inhibits proliferation of 
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hantaviruses and that viral N-protein RNA stimulates RIG-I. This effect is dependent on 
virus pathogenicity. In contrast, the cytoplasmic tail of the G1 protein of NYV, but not 
of PHV blocks RIG-I directed interferon-I (IFN-I) transcription (Alff et al., 2006). 
Activation of PRRs leads to secretion of inflammatory cytokines and expression of 
antiviral proteins. Thus, pathogenic hantaviruses evade type-I interferon response. 
Accordingly, delayed expression of MxA, an important ISG, was demonstrated after 
infection of primary endothelial cells with pathogenic HTNV and NYV in contrast to 
rather nonpathogenic TULV and PHV (Geimonen et al., 2002; Kraus et al., 2004).  
Dendritic cells can be infected with HTNV in vitro. However, HTNV-infected 
dendritic cells do not undergo apoptosis after infection (Raftery et al., 2002) in contrast 
to other viruses such as HSV (Muller et al., 2004). Instead they fully mature and acquire 
T-cell stimulatory capacity (Raftery et al., 2002). The amount of CD8-T-cells is 
increased after hantavirus infection and the CD4+/CD8+ T-cell ratio is reversed (Chen 
& Yang, 1990; Van Epps et al., 2002). CD8-T-cells are important for clearance of 
infected cells, but thereby destroy endothelial cells that are important for vascular 
integrity. Thus, lymphocytes are discussed to mediate immunopathogenesis leading to 
haemorrhages. Supporting this notion, the frequency of virus-specific CD8-lymphocytes 
was shown to correlate with the severity of disease (Kilpatrick et al., 2004).  
The viral nucleoprotein is the most abundant component in humans after infection 
and the early humoral response is basically directed against viral N-protein 
(immunoglobolin A (IgA), IgM, IgG) (Vapalahti et al., 2001). Antibodies directed to N-
protein are detected early after infection (Kallio-Kokko et al., 2000; Lundkvist et al., 
1993; Lundkvist et al., 1996), whereas antibodies directed to viral G-proteins can only 
be detected later on (Maes et al., 2004). Although the virus is eliminated by the human 
host, neutralizing antibodies can be detected many years after infection, suggesting life-
long protection against reinfection (Settergren et al., 1991; Ye et al., 2004). So far 
published results provide some evidence for the concept of immunopathogenesis. 
However, immune responses after hantavirus infection in humans remain to be analysed 
in more detail. 
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1.6.3 The concept of immunopathogenesis 
During hantavirus infection haemorrhages and decreased platelet count are striking and 
life-threatening symptoms, but how they are caused is still poorly understood. Bleedings 
are caused by disturbance of the integrity of the endothelial barrier. It is known that 
hantaviruses infect endothelial cells in vivo and in vitro (Zhu, 1988), but so far no direct 
cytopathic effect was observed. Therefore, haemorrhages probably occur due to a 
mechanism other than direct virus-induced damage of the cell. One feasible explanation 
is offered by the concept of immunopathogenesis (figure 4): an uncontrolled excessive 
immune response of the host (Khaiboullina & St Jeor, 2002).  
 
 
Figure 4: Working hypothesis of hantavirus-induced immunopathogenesis in humans.  
Viral particles are taken up in the lung where DCs are among the first cells that are infected. They can 
function as carriers and transport the virus throughout the human body presenting hantaviral antigen on 
their surface. Furthermore, hantaviruses stimulate DC maturation. Thus T-cells can be stimulated and 
virus specific effector cells are generated. Endothelial cells are infected and also present hantaviral 
antigen on their surface. By this they are becoming potential targets for virus-specific CTLs. Hence the 
endothelium is disturbed leading to increased permeability of the endothelial barrier and increased viral 
dissemination. 
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1.7 Biosafety in Hantavirus research 
According to Centers for Disease Control and Prevention agents with potential for 
aerosol transmission and disease that may have serious or lethal consequences must be 
handled under biosafety level 3 (BSL-3) conditions (CDC, 2007). Thus, experimental 
procedures with hantaviruses must be accomplished in a BSL-3 laboratory. This implies 
that primary and secondary barriers to protect people from exposure to potentially 
infectious aerosols must exist. Nevertheless, in recent years several infections with 
hantaviruses after laboratory work occurred (Desmyter et al., 1983; Lloyd et al., 1984; 
Tsai, 1987; Umenai et al., 1979), indicating the importance of high biosafety when 
working with hantaviruses. For this reason experiments with hantaviruses are 
cumbersome as well as time-consuming and experimental possibilities are more 
restricted in contrast to research under biosaftey level 1 or 2.  
 
1.8 Objectives 
The hallmarks of hantavirus infection are haemorrhages and thrombocytopenia, but why 
these symptoms occur is not completely understood. The aim of this study is to provide 
a better understanding of the mechanisms underlying these symptoms. Therefore, the 
interaction of hantaviruses and cells of the haemostatic system, i.e. megakaryocytes and 
platelets, will be analysed. Moreover, the human immune response after hantavirus 
infection will be investigated. The questions that will be solved are: (1) Do different 
hantaviruses infect megakaryocytes and/or platelets? (2) Is formation of platelets 
abnormal, resulting in less or defective platelets? (3) Do hantaviruses directly influence 
megakaryocyte/platelet function? (4) How is the immune system involved, and is the 
thesis of hantavirus-associated immunopathogenesis supported?  
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2 Material and Methods 
2.1 Material 
2.1.1 Cells and cell lines 
Cells Description Source 
HEL cells human erythroleukemia cell line kindly provided by Lüder Wiebusch 
Huh7 human hepatoma cell line ATCC nr.: CCL-185 
K562 cells human chronic myeloid leukemia in 
blast crisis 
kindly provided by Harald Schulze 
L8057 cells murine megakaryoblastic cell line kindly provided by Harald Schulze 
Meg-01 cells human chronic myeloid leukemia       
in megakaryocytic blast crisis 
kindly provided by Monika Bigalke 
monocytes primary human monocytes isolated from buffy coats 
PBMCs peripheral blood mononuclear cells isolated from buffy coats 
platelets primary human platelets isolated from freshly drawn blood 
TF-1 cells human erythroleukemia cell line kindly provided by Carmen 
Scheibenbogen 
VeroE6 cells african green monkey kidney cells ATCC nr.: CRL-1586 TM 
 
2.1.2 Hantavirus strains 
Virus strain Description Source 
HTNV 
(strain76-118) 
pathogenic hantavirus,           
Asia 
kindly provided by Âke Lundkvist, 
Stockholm 
TULV 
(strain Moravia) 
rather nonpathogeic hantavirus, 
Europe 
kindly provided by Âke Lundkvist, 
Stockholm 
PHV 
(type 3571) 
rather nonpathogeic hantavirus, 
USA 
kindly provided by Robert Tesh, 
Galvestone 
 
2.1.3 Chemicals 
Product Manufacturer 
acetone Roth (Karlsruhe, Germany) 
APS (ammonium persulfate) Roth (Karlsruhe, Germany) 
BME (basal medium with Earls’s salt) 10x Biochrom AG (Berlin, Germany) 
bromphenol blue Serva (Heidelberg, Germany) 
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Product Manufacturer 
BSA (bovine serum albumin) PAA (Pasching, Austria) 
DMSO  (Dimethylsulfoxid) Roth (Karlsruhe, Germany) 
EMEM (minimal essential medium) PAA (Pasching, Germany) 
ethanol Roth (Karlsruhe, Germany) 
FCS (fetal calf serum) Biochrom AG (Berlin, Germany) 
Ficoll-Hypaque PAA (Pasching, Austria) 
formaldehyde Merck (Darmstadt, Germany) 
glycine Roth (Karlsruhe, Germany) 
GM-CSF (granulocyte-macrophage 
colony-stimulating factor) 
Immunotools (Friesoythe, Germany) 
HBSS (hanks’ balanced salt solution) PAA (Pasching, Austria) 
HCl Roth (Karlsruhe, Germany) 
HEPES (N-2-hydroxyethylpiperazine-N'-2-
ethane-sulfonic acid) 
PAA (Pasching, Austria) 
L-glutamine PAA (Pasching, Austria) 
mercaptoethanol Merck (Darmstadt, Germany) 
methanol Roth (Karlsruhe, Germany) 
milk powder Sufocin (Zeven, Germany) 
PBS (phophat buffered saline) PAA (Pasching, Austria) 
penicillin/streptomycin (1000 U (units)/ml) PAA (Pasching, Austria) 
PGE1 (prostaglandin) Sigma Aldrich (Deisendorf, Germany) 
Poly-L-Lysine Biochrom (Berlin, Germany) 
RNaseA Qiagen (Hilden, Germany) 
Rotiphorese-Acrylamide Roth (Karlsruhe, Germany) 
RPMI Medium PAA (Pasching, Austria) 
SDS Merck (Darmstadt, Germany) 
staurosporine Sigma-Aldrich (Deisendorf, Germany) 
TEMED ICN Biomedicals (Irvine, USA) 
Tris-HCl Roth (Karlsruhe, Germany) 
thrombin Sigma-Aldrich (Deisendorf, Germany) 
triton X-100 Roche (Mannheim, Germany) 
trypan blue Serva (Heidelberg, Germany) 
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Product Manufacturer 
trypsin/EDTA Invitrogen (Karlsruhe, Germany) 
tween 20 Merck (Darmstadt, Germany) 
PMA (4-β−phorbol-12-myristate-13-acetate) Sigma-Aldrich (Deisendorf, Germany) 
fibrinogen  Invitrogen (Karlsruhe, Germany) 
fibronectin Invitrogen (Karlsruhe, Germany) 
vitronectin Sigma Aldrich (Deisendorf, Germany) 
ultra pure water PAA (Pasching, Germany) 
 
2.1.4 Equipment 
Product Manufacturer 
autoclave Getinge (Rastatt, Germany) 
balance Sartorius (Göttingen, Germany) 
blockheater Roth (Karlsruhe, Germany) 
CCD-Camera Bioblock Scientific (Illkirch, France) 
CCD-Camera (L3-lab) Raytest (Strabenhardt, Gemany) 
centrifuge Megafuge 2.0 R (Hanau, Germany) 
CO2 Incubator Heraeus (Kleinostheim, Germany) 
convocal laser scanning microscope Nikon Instruments Europe B.V. (Amstelveen, 
the Netherlands) 
counting chamber, Neubauer Improved Marienfeld (Lauda-Königshofen, Germany) 
cryo container Nalgene Nunc (Wiesbaden, Germany) 
electron microscope (TEM 902)  Carl Zeiss SMT AG 
electrophoresis system Mini-Protean III Bio-Rad (München, Germany) 
ELISA reader Biochrom Anthos (Cambridge, UK) 
FACScalibur Becton Dickinson (Heidelberg, Germany) 
fluorescence microscope  Olympus (Hamburg, Germany) 
Laminar flow box Herasafe Heraeus (Kleinostheim, Germany) 
microscope, Axiovert 25 Carl Ziess AG (Jena, Germany) 
pH-meter pH 320 WTW (Weilheim, Germany) 
refrigerator Liebherr (Oberhausen, Germany) 
semi-dry blot chamber OWI (Portsmouth, Netherlands) 
slow-scan-charge-coupled-device camera Pro Scan (Scheuring, Germany) 
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Product Manufacturer 
ultramicrotome (Ultracut S) Leica (Wetzlar, Germany) 
vortexter Reax 2000 Reax Heidolph (Schwabach, Germany) 
water bath Lauda (Königshofen, Geramny) 
whatman paper Schleier & Schuell GmbH (Dassel, Germany) 
 
2.1.5 Consumables 
Product Manufacturer 
6-, 12-, 24-, 96-well plates Nunc (Wiesbaden, Germany) 
cell culture flask: T25, T75, T125 Nunc (Wiesbaden, Germany) 
cover slides Roth (Karlsruhe, Germany) 
eppendorf tubes VWR (Darmstadt, Germany)  
FACS tubes VWR (Darmstadt, Germany) 
falcon tubes VWR (Darmstadt, Germany) 
LS-column Miletnyi (Bergisch Gladbach, Germany) 
microscope slides Roth (Karlsruhe, Germany) 
whatman paper Schleicher & Schuell (Dassel, Germany) 
pipet tips Roth (Karlsruhe, Germany) 
serological pipets TPP (Trasadingen, Switzerland) 
PVDF membrane  Milipore (Schwalbach/Ts., Germany) 
sterile filters Schleicher und Schüll (Dassel, Germany) 
uncoated 96-well plates Sarstedt (Nürnberg, Germany) 
 
2.1.6 Primary monoclonal antibodies and polyclonal serum 
Specificity Species Application Manufacturer 
β-Actin mouse WB Acris (Herford, Germany) 
CD14 mouse FACS BD Bioscience (München, Germany) 
CD29 mouse FACS, IF ImmunoTools (Friesoythe, Germany) 
CD41 mouse FACS, IF ImmunoTools (Friesoythe, Germany) 
CD42 mouse FACS, IF ImmunoTools (Friesoythe, Germany) 
CD51 mouse FACS, IF ImmunoTools (Friesoythe, Germany) 
CD55 mouse FACS Southern Biotechnology Associates, 
(Birmingham, USA) 
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Specificity Species Application Manufacturer 
CD61 mouse WB BD Bioscience (München, Germany) 
CD61 mouse FACS, IF ImmunoTools (Friesoythe, Germany) 
CD62P mouse FACS ImmunoTools (Friesoythe, Germany) 
CD63 mouse FACS BD Bioscience (München, Germany) 
CD69 mouse FACS BD Bioscience (München, Germany) 
CD83 mouse FACS BD Bioscience (München, Germany) 
CD86 mouse FACS BD Bioscience (München, Germany) 
CD209 (DC-SIGN) mouse FACS BD Bioscience (München, Germany) 
gC1qR mouse FACS Upstate Biotechnology (NY 
State, USA) 
Hantavirus N-protein rabbit WB, IF (Razanskiene et al., 2004) 
ICAM-I mouse FACS BD Bioscience (München, Germany) 
IgG1 mouse FACS, IF BD Bioscience (München, Germany) 
IgG2b mouse FACS, IF ImmunoTools (Friesoythe, Germany) 
MxA mouse WB (Flohr et al., 1999) 
RIG-I rabbit WB Alexis (Lörrach, Germany) 
 
2.1.7 Secondary antibodies and fluorescent dyes 
Antibody Species Application Manufacturer 
AnnexinV - FACS Santa Cruz Biotechnology 
(Heidelberg, Germany) 
DAPI - IF Invitrogen (Karlsruhe, German) 
FITC (fluorescein 
isothiocyanate) 
mouse FACS, IF Dianova (Hamburg, Germany) 
HRP mouse WB Dako (Glostrup, Denmark) 
HRP rabbit WB Dako (Glostrup, Denmark) 
PE (phycoerithrin) mouse FACS Dianova (Hamburg, Germany) 
Propidiumiodide (PI) - FACS Santa Cruz Biotechnology 
(Heidelberg, Germany) 
Rhodamine-Phalloidine - IF Invitrogen (Karlsruhe, Germany) 
flouorescent fibrinogen - FACS Invitrogen (Karlsruhe, German) 
Texas Red mouse IF Dianova (Hamburg, Germany) 
TexasRed rabbit IF Dianova (Hamburg, Germany) 
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2.1.8 Kits 
Kit Manufacturer 
EZ4U Cell Proliferation Assay Biomedica (Austria) 
Monocyte Isolation Kit II Miltneyi Biotec (Bergisch Gladbach, Germany) 
In Situ Cell Death Detection Kit Roche (Mannheim, Germany) 
Super-Signal® West Dura Extended 
Duration Substarte 
Thermo Scientific (USA, Rickford) 
Venor® GeM-Mycoplasma Detection Kit Minerva Biolabs (Berlin, Germany) 
 
2.1.9 Software 
Software Manufacturer 
Adobe Photoshop  Adobe Systems Incorporated (München, 
Germany) 
CellQuest Pro Becton Dickinson (Heidelberg, Germany) 
Corel Draw  Corel Corporation (Unterschleißheim, Germany) 
PRISM  GraphPad Software Inc. (La Jolla, USA) 
TINA Raytest (Straubenhardt, Germany) 
 
2.1.10 Buffers and Solutions 
Buffer/ Solution Ingredients 
0,1% triton 0.1% triton on PBS 
10% resolving gel 3.3 ml 30% acrylamide/0.8% bisacrylamide 
(37:55:1), 2.5 ml 1.5 M Tris-HCl, pH 8.8, 100 µl 
10% SDS, 100 µl 10% APS, 6 µl TEMED, 4ml H2O 
2x BME 100 ml 10x BME, 10 ml L-glutamine, 40 ml 
NaHCO3, 350 ml H2O 
4% formaldehyde solution 4% Formaldehyde in PBS 
acetone/methanol acetone : methanol, 1:1 
AnnexinV Buffer 10 nM HEPES, 0.14 M NaCl, 5 mM CaCl2, 5% FCS, 
0.02% sodium acid in H2O 
antibody dilution buffer PBS, 5% FCS, 0.1% tween 
blocking solution PBS, 1% FCS 
buffycoat medium RPMI, 0.2mM EDTA 
coating buffer PBS, 0.5% BSA 
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Buffer/ Solution Ingredients 
FACS block PBS, 10% FCS, 0.2% sodium acid 
FACS fixation solution PBS, 1% formaldehyde 
FACS wash PBS, 1% FCS, 0.02% sodium acid 
fixation buffer (electron microscopy) 2.5% Gutaraldehyde in HEPES 
fixation buffer II (electron microscopy) 1% OsO4, 1% uranyl acetate and 0.1% tannic acid in 
HEPES-buffer 
HEPES Tyrodes buffer 137 mM NaCl, 2.9 mM KCl, 0.4 mM NaH2PO4, 12 
mM NaHCO3, 5 mM glucose, 10 mM HEPES 
overlay medium 1:1 mixture of : 1% agarose: 2x BME, 10% FCS, 
2.5% HEPES, 100 IU/ml penecillin, 100 IU/ml 
streptomycin 
PBS 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24g 
KH2PO4, ad 1l H2O 
protein lysis buffer 250 mM tris, 2% SDS, 10% glycerine, 5% 
mercaptethanol, 0.01% bromphenol blue, in H20 
SDS buffer 60 g Tris, 288 g Glycin, 20 g SDS, H2O ad 2l 
semi dry buffer 200 ml methanol, 1.87 ml 20% SDS solution, 5.2 g 
Tris, 2.425 g tris, H2O ad 1 l 
stacking gel 0.83 ml 30% acrylamide/0.8 % bisacrylamide 
(37:55:1), 1.25 ml 0.5 M tris-HCl, pH 6.8, 50 µl 10% 
SDS, 50 µl 10% APS, 6 µl TEMED, 2.8 ml H2O 
stripping solution 100 mM tris, 2% SDS, 0.1% mercaptoethanol 
virus dilution buffer Hank´s balanced salt solution, 2% FCS, 100 IU/ml 
penecillin, 100 IU/ml streptomycin, 2% HEPES 
washing buffer PBS, 0.15% tween 
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2.2 Methods 
2.2.1 Cell Biological Methods 
2.2.1.1 Cell Culture 
HEL, K562 and Meg-01 cells were maintained in RPMI medium supplemented with 
10% FCS, 2mM L-glutamine, penicillin and streptomycin. Vero E6 cells were grown in 
minimal essential medium (MEM) supplemented with the same additives. TF-1 cells 
were maintained in RPMI medium, supplemented with 2 mM L-glutamine, 10% FCS 
and 5 ng/ml recombinant human GM-CSF. L8057 cells were maintained in RPMI, 10% 
FCS and 2 mM L-glutamine. Platelets were cultured in Hepes-Tyrodes Buffer. 
Monocytes and Lymphocytes were cultured in RPMI medium supplemented with 10% 
FCS, 100 mM Hepes, 2mM L-glutamine, penicillin and streptomycin. 
 
2.2.1.2 Stimulation of cells 
HEL cells or Vero E6 cells were stimulated with 10 nM PMA (4-β−phorbol-12-
myristate-13-acetate) 1 day before or 1 hour (h) after infection. 
 
2.2.1.3 Isolation of platelets 
Platelets were isolated from freshly drawn citrated blood. The first 2 ml of blood were 
discarded. Blood was centrifuged at 80 g for 15 min. After centrifugation platelet rich 
plasma (prp) was pipetted off and 1 μl PEG1/ml was added to platelet rich plasma. After 
further centrifugation (200 g, 5 min) platelets were concentrated. Isolated platelets were 
resuspended in Hepes-Tyrodes buffer. For stimulation 0.2 U (units)/ml thrombin were 
added. 
 
2.2.1.4 Determining cell count 
For cell counting, cells were diluted with a 0.5% trypan blue solution to differentiate 
between living and dead cells as trypan blue stains only dead cells. 10 µl of the cell 
dilution were filled evenly at once to hematocytometer chamber. Cells were allowed to 
settle down for two minutes. Cells in one big square (16 small squares) were counted 
and cell number was determined by following formula: 
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For counting of platelets, cells on 80 squares of the middle of the counting chamber 
were counted. Cell number was verified by following formula: 
 
 
 
2.2.1.5 Isolation of peripheral blood mononuclear cells (PBMCs) 
PBMCs were isolated from buffy coat preparations derived from healthy human donors. 
Blood was diluted with buffy coat medium 1:2. The mixture was layered on Ficoll-
Hypaque and centrifuged (20 min, 800 g, room temperature, no brake). Subsequently 
PBMCs, concentrated in a white layer on Ficoll-Hypaque, were collected and washed 
with medium. To remove residual platelets from PBMCs, cells were washed for a 
second time.  
 
2.2.1.6 Isolation of monocytes 
Monocytes were isolated from PBMCs by using the Monocyte Isolation Kit II, 
according to the manufacturer’s protocol. In brief, PBMCs were diluted in 10 ml 
medium and layered on diluted Ficoll-Hypaque (1.4 ml in PBS). After centrifugation 
(800 g, 25 min, room temperature, no brake) PBMC layer was harvested. Cells were 
washed with ice-cold MACS buffer and blocked for 10 min at 4°C with FcR blocking 
reagent and 200 μl of monocytes-Biotin-Antibody-Cocktail (containing antibodies 
directed against anti-human CD3, CD7, CD16, CD19, CD56, Glycophorine A). Thus, 
non-monocytic cells were labelled. To deplete labelled cells, 400 μl Anti-Biotin Micro 
Beads were added. After 15 min of further incubation cells were adjusted to an 
equilibrated LS column. Monocytes were collected in flow through. 
 
2.2.2 Virological Methods 
2.2.2.1 Safety aspects 
Working with pathogenic hantaviruses has to be performed under laboratory safety 3 
conditions. This implies performing all infectious work in a special laboratory with low 
pressure and wearing protective clothing. Handling viable virus has to be performed 
 25
Material and Methods 
 26 
under laminar flow box exclusively. All kinds of waste must be autoclaved before being 
discarded. 
 
2.2.2.2 Virus stock production 
Virus stocks of HTNV, Tula and PHV were propagated on VeroE6 cells. Medium of 
cells of a T75 flask was taken off. Cells were infected with 500 µl stock and kept on a 
shaker at 37°C for one h. Afterwards 25 ml of Medium was added and cells were kept in 
a humidified atmosphere at 37°C for 7-10 days. Culture supernatant was harvested, 5% 
inactivated FCS added, aliquoted and stored at –80°C. To increase viral titers cell 
culture supernatant of infected VeroE6 cells was concentrated in an ultracentrifuge at 
130,000g at 4°C for 3 h. For infection of platelets virus stocks were ultracentrifugated 
and virus resuspended in Hepes-Tyrodes Buffer. Virus stocks were tested for 
mycoplasma by polymerase chain reaction (PCR) regularly. 
 
2.2.2.3 Virus infection of cells 
Virions at respective multiplicity of infection (MOI) (0.1, 1.0 or 1.5) were allowed to 
adsorb to cells for 1 h. After washing three times with medium cells were seeded in a 
cell culture vessel and incubated in a humidified atmosphere at 37°C. Uninfected cells 
treated with medium instead of virions were used as mock control.  
 
2.2.2.4 Virus titration 
Hantavirus titers were determined as described recently (Heider et al., 2001). Briefly, 
Vero E6 cells were infected by serial dilutions of supernatants for 1 h to allow 
adsorbance of virus particles. Thereafter, cells were overlaid with medium containing 
0.5% agarose. After 7 days of incubation at 37°C the overlay was removed, cells were 
washed with PBS and fixed with methanol for 10 min. After incubation with a 
hantavirus N-protein-specific polyclonal rabbit serum the SuperSignal West Dura 
Extended Duration Substrate kit was used according to the manufacturer’s instructions 
to visualize antigen-positive foci. Finally, the antigen-positive foci were counted to 
calculate virus titers, which are expressed as FFU/ml. 
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2.2.2.5 Kinetics 
To analyse virus growth in different cells growth kinetics were performed. Cells were 
infected and seeded to cell culture vessels in adequate concentration. At indicated time 
points supernatant was harvested. Viral titers were analysed by titration. 
 
2.2.3 Molecular Biological Methods 
2.2.3.1 Cell proliferation 
For differentiating between dead and vital cells a 0.5% trypan blue solution was used. 
10 µl of the cell dilution were filled into a hematocytometer chamber. Dead and live 
cells were counted and cell number was determined. 
 
2.2.4 Electron microscopy 
Cells were fixed in fixation buffer for 1 h at room temperature and centrifuged. Pellets 
were embedded in agar blocks by mixing equal volumes of cell-pellet and low-melting-
point agarose. Small agar blocks were cut to size and postfixed with fixation buffer II. 
Samples were dehydrated stepwise in graded ethanol series and embedded in epon resin, 
which was subsequently polymerized. Thin sections were prepared with an 
ultramicrotome and counterstained with 2% uranyl acetate and lead citrate. The sections 
were examined using a TEM 902 at 80 kV. Obtained images were digitized using a 
slow-scan charge-coupled-device camera. 
 
2.2.5 Proteinchemistry 
2.2.5.1 Immunoblot 
HEL cells were lysed in lysis buffer followed by denaturation by heating the sample for 
5 min at 95°C. Proteins were separated by 10% sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis and transferred onto a PVDF membrane. 
Subsequently membrane was blocked in 5% milk powder for one hour. The membrane 
was incubated with first antibody at 4°C over night. For detection of primary antibodies 
an anti-rabbit or anti-mouse peroxidase-conjugated antibody was used. Immunoblots 
were developed by using SuperSignal® West Dura Extended Duration Substrate kit 
according to the manufacturer’s protocol.  
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2.2.6 Immunological Methods 
2.2.6.1 Immunofluorescence 
Coverslides were washed twice with water and sterilized with 70% ethanol. After 
drying, cover slides were coated with poly-l-lysine, incubated at 37°C for 30 min and 
washed twice with water. Cells were harvested and washed three times, resuspended in 
medium and allowed to adhere to poly-l-lysine coated coverslides for 15 min at 37 °C. 
Cells were either fixed with acetone/methanol for 10 min or with 4% formaldehyde for 
60 minutes. Formaldehyde fixed cells were permeabilized with 0.1% Triton for 5 min 
and washed in PBS three times. Before staining cells were blocked in blocking solution 
for 30 min at 4°C followed by three washing steps in PBS. First antibody was diluted in 
dilution buffer. Coverslides were incubated at 37°C in a moist chamber in the dark for 
one hour. For detection FITC or Texas Red labelled secondary antibodies (1:400) were 
used. 
 
2.2.6.2 Flow cytometry 
For surface staining cells were harvested and washed twice in ice-cold FACS washing 
solution. Thereafter, cells were resuspended in 50 µl FASC blocking solution, 
containing the primary antibody in appropriate dilution, and incubated for 1 h. After 
incubation, cells were again washed twice with FACS wash and for unconjugated 
primary antibodies secondary antibody, diluted in FACS block solution, was added. 
After 45 min the cells were washed with FACS wash solution and resuspended in FACS 
fixation solution. For quantifying fluorescence of labelled cells a FACSCalibur® was 
used. Results were evaluated with the flow cytometry analysis software program 
CellQuestPro®. 
 
2.2.6.3 Endoreplication 
For analysis of endoreplication HEL cells were harvested and adjusted to 1x106 
cells/ml. After fixation in ice-cold 70% ethanol cells were washed with PBS. To 
eliminate RNA, RNA was digested with RNase I (50 μg/ml) for 30 min. 
Propidiumiodide was added 20 min prior to FACS analysis at 50 μg/ml. 
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2.2.6.4  Analysis of cell death by terminal-desoxynucleotidyl-transferase-mediated 
2-Deoxyuridine 5’-Triphosphate (dUTP) nick end labeling (TUNEL) 
technology 
To detect cells death via DNA strand breaks TUNEL technology was used according to 
manufacturer’s protocol (In Situ Cell Death Detection Kit, Roche). Briefly, cells were 
fixed in 4% formaldehyde on coverslides. Cells were permeabilized with 0.1 % triton 
solution and TUNEL reaction mixture was added. Cells were analysed by confocal 
laserscan microscopy. 
 
2.2.6.5 Analysis of cell death by flow cytometry 
For quantification of apoptosis cells were harvested, washed once with AnnexinV buffer 
and incubated with FITC-labelled AnnexinV for 20 min at 4°C. Cells were washed 
again with AnnexinV buffer and fixed in fixation buffer. As a positive control cells were 
incubated with staurosporine (0.5 μg/ml) over night. Finally cells were analysed by flow 
cytometry as described before. 
 
2.2.6.6 Adhesion assay 
To test adhesion capacities of HEL cells uncoated 96-well plates were coated with 10 
μg/ml fibrinogen, 10 μg/ml fibronectin or 0.5 μg/ml vitronectin at 4°C overnight. After 
washing off ligands three times with PBS, wells were coated with coating buffer for 60 
min at 37 °C. HEL cells that had been infected with HTNV and harvested three days 
post infection, were adjusted to 5x104 cells/well and allowed to adhere to ligands for 90 
minutes. Non-adherent cells were washed off three times with PBS. The number of 
adherent cells was quantified by using a colorimetric assay (MTT assay) according to 
manufacturer’s protocol. The assay is based on the fact that living cells metabolize 
tetrazolium salt into its deep red coloured formazan derivative. For quantification of 
adherent HEL cells, cells were covered with 200 μl cell culture medium and 20 μl of 
dye substrate. Optical density (OD) was recorded after 3 h at 450 nm. Experiments were 
done in triplicates.  
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2.2.7 Internalisation assay 
For the analysis of receptor internalisation cells were infected at MOI 1.5 three days pi. 
Cells were stained for CD29 or CD61 in culture medium for 1 h. After being washed 
twice, cells were incubated for 2 h at either 4°C or 37°C. Subsequently, cells were 
stained for remaining cell surface-bound antibody with a secondary antibody. The 
reduction in specific staining at 37°C compared to the specific staining at 4°C represents 
the level of internalisation. 
 
2.3 Statistical methods  
The Wilcoxon test was used to analyse inter-group differences. A value of p<0.05 was 
considered significant (two tailed). Box-Whisker plots cover data values between 10th-
90th percentiles; the central line indicates the median. Endpoints of whiskers represent 
true data points for smallest and biggest values.  
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3 Results 
3.1 Hantaviruses and cells of the haemostatic system  
Megakaryocytes are myeloid cells that arise from haematopoietic stem cells in the bone 
marrow. Several steps of differentiation and maturation are required until the mature 
megakaryocytes are formed (megakaryopoiesis). These cells further develop into 
proplatelets that are released into the blood. Subsequently platelets are produced by 
cytoplasmic fragmentation (thrombopoiesis). Platelets are primarily known for their 
pivotal function in blood clotting, but are also important immune cells.  
Acute thrombocytopenia during hantavirus infection represents an important 
factor in the cascade of events leading to haemorrhages. Surprisingly, megakaryocytes 
and platelets have not been of prime interest in the field of hantaviral pathogenesis so 
far. In 1977 megakaryocytes of patients suffering from Korean haemorrhagic fever were 
analysed by light and electron microscopy (Lee et al., 1977). They found that in 12 out 
of 14 patients platelet formation by megakaryocytes was absent. Furthermore in 2004 
Liang and coworkers detected hantavirus antigen in 20% of megakaryocytes in the bone 
marrow of HTNV-infected patients (Liang et al., 2004).  
In order to explore the mechanisms underlying acute thrombocytopenia and 
haemorrhages during hantavirus infection, we analysed the interaction of hantaviruses 
with cells of the haemostatic system: human megakaryocytes and platelets. 
Hantaviruses might interfere at different developmental stages with megakaryopoiesis 
and thrombopoiesis (figure 5). Infection or simply interaction of the virus with 
differentiating megakaryocytes could impair cellular function on several stages and/or 
formation of platelets. In addition, hantaviruses could modulate the function of platelets.  
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Figure 5: Simplified scheme of megakaryopoiesis and thrombopoiesis.  
Thin arrows demonstrate possible sides of interaction between cells and viruses. 
 
3.2 Megakaryocytic cell lines as a model for megakaryopoiesis 
Isolation and cultivation of primary megakaryocytes is very difficult to achieve. 
Therefore, megakaryocytic cell lines serve as model systems to analyse 
megakaryopoiesis in vitro. In this study the human megakaryocytic cell lines TF-1, 
HEL, K562, Meg-01 that are arrested at different stages of differentiation and the 
murine megakaryocytic cell line L8057 were used. HEL, Meg-01, K562 and L8057 
cells further differentiate along the megakaryocyte lineage after stimulation with low 
doses of PMA (Alitalo, 1990; Isakari et al., 2009; Long et al., 1990). TF-1 cells undergo 
terminal megakaryocytic differentiation when stimulated with PMA and TPO (Testa et 
al., 1998), but apoptosis is induced simultaneously (Chao et al., 1997). In this study, 
therefore, only unstimulated TF-1 cells were analysed. 
 32 
TF-1 is a premyeoloid cell line originally isolated from bone marrow of a patient 
suffering from erythroleukemia. It represents a less differentiated cell type (Kitamura et 
al., 1989). HEL cells, isolated from peripheral blood of a 30-year-old man with 
Results 
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erythroleukemia, and K562 cells, isolated from the pleural effusion of a 53-year-old 
woman suffering from chronic myeloid leukemia in blast crisis, represent early 
megakaryoblast stages (Lozzio & Lozzio, 1975; Martin & Papayannopoulou, 1982). 
Meg-01 cells were established from the bone marrow of a 55-year-old man with chronic 
myeloid leukemia in megakaryocytic blast crisis, and also originate from the 
megakaryocytic lineage (Ogura et al., 1985). L8057 cells are murine megakaryoblast 
cells isolated from an irradiated C3H/He mouse (Ishida et al., 1993).  
Of all cells used during these experiments TF-1 cells represent the most 
undifferentiated stage. K562 and HEL cells comprise erythroid as well as 
megakaryocytic markers. It is assumed that they are derived from a haematopoietic 
progenitor cell that gives rise to both cell types (Gewirtz et al., 1982; Martin & 
Papayannopoulou, 1982). HEL cells carry markers that are already expressed by 
undifferentiated megakaryocytes whereas K562 cells only commit to the 
megakaryocytic lineage after stimulation with PMA. Meg-01 cells show many 
megakaryocytic characteristics but also express CD14 and BA-1 as non-megakaryocytic 
proteins. They are known to produce platelet-like particles (Ogura et al., 1985; Takeuchi 
et al., 1991). Figure 6 shows surface expression of markers of megakaryopoiesis on the 
human cell lines used in this study. 
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Figure 6: Expression of markers of megakaryopoiesis on unstimulated (A) and PMA-stimulated (B) 
human megakaryocytic cell lines.  
Unstimulated cells (A) and cells stimulated with 10 nM PMA (B) were analysed for CD41 (integrin αIIb), 
CD61 (integrin β3), and CD42 (GPIb) by flow cytometry. Grey filled histograms represent isotype 
controls, black histograms show specific staining with accordant primary antibody. On x-axis 
fluorescence intensity, on y-axis cell count is indicated. Numbers in the right corner of histograms 
indicate mean fluorescent intensity. Data shown are representatives of three independent experiments 
 
Analysis of typical surface markers of megakaryocytic cells showed, that different 
cell lines express on the surface markers of megakaryopoiesis with different densities. 
TF-1 cells represent a very early phase within megakaryopoiesis. Late 
megakaryopoiesis marker CD42 is not expressed at all. However, low expression of 
CD41 and CD61 was detected. Unstimulated K562 cells express hardly any marker 
protein, but upon stimulation with PMA expression of CD61 is increased, indicating 
terminal differentiation along the megakaryocytic lineage. Untreated HEL cells express 
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CD41 and CD61 on their surface, but no CD42. Stimulation leads to an increased 
expression of both early markers, especially CD61. Meg-01 cells only express low 
amounts of CD41 and CD61 when not stimulated with PMA. After stimulation 
expression of both markers is slightly increased. 
 
3.3 Hantavirus receptors on megakaryocytic cells 
For hantaviruses different receptors for viral entry have been detected. Highly 
pathogenic hantaviruses enter cells via β3 integrins whereas rather non-pathogenic 
hantaviruses use β1 integrin for entry (Gavrilovskaya et al., 1999; Gavrilovskaya et al., 
2002). Furthermore, decay-accelerating factor CD55/DAF and the receptor for globular 
head domain of complement component C1q (gC1qR) have been shown to mediate 
entry of HTNV into host cells (Choi et al., 2008; Krautkramer & Zeier, 2008). To 
investigate which of these receptors are expressed on the surface of the megakaryocytic 
cell lines used, cells were analysed by flow cytometry (Figure 7: Surface expression of 
hantavirus receptors on human megakaryocytic cells. (Figure 7).  
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Figure 7: Surface expression of hantavirus receptors on human megakaryocytic cells.  
Unstimulated cells (A) and cells stimulated with 10 nM PMA (B) were analysed for β1, β3, CD55/DAF 
and gC1qR by flow cytometry. Grey filled histograms represent isotype controls, black histograms show 
specific staining with accordant primary antibody. On the x-axis fluorescence intensity, on the y-axis cell 
count is indicated. Numbers in the right corner of histograms give the mean fluorescent intensity. Data 
shown are representatives of three independent experiments.  
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CD29 (β1) and CD55/DAF were strongly expressed on all cell lines analysed. 
When stimulated with PMA, expression of CD55/DAF was slightly decreased on HEL 
cells but increased on Meg-01 cells. Stimulation with PMA did not significantly alter 
CD29 (β1) expression. CD61 (β3) was already strongly expressed on unstimulated HEL 
cells, barely found on unstimulated Meg-01 and TF-1 cells, and undetectable on 
unstimulated K562 cells. After PMA-induced differentiation into megakaryocytes, 
expression of CD61 was strongly increased on all cell lines tested. In contrast to the 
other hantavirus receptors, gC1qR was found neither on unstimulated nor on PMA-
stimulated megakaryocytic cells. 
 
3.4 Infection of megakaryocytic cell lines with hantaviruses 
3.4.1 Switch to high-level HTNV infection in differentiating HEL cells 
Amongst the megakaryocytic cell lines tested HEL cells showed the strongest surface 
expression of hantavirus receptors. For this reason, the susceptibility of unstimulated 
and PMA-stimulated HEL cells to pathogenic HTNV and to the rather non-pathogenic 
hantavirus strains TULV and PHV was analysed by immunohistochemistry (figure 8).  
 
 
Figure 8: Immunofluorescence microscopy analysis of unstimulated and PMA-stimulated HEL cells 
infected with HTNV, TULV or PHV.  
Unstimulated and PMA-stimulated HEL cells were infected with hantavirus strains as indicated and 
stained for viral N-protein using a rabbit-derived polyclonal antiserum (green) 3 days pi. Nuclei were 
stained with DAPI (blue). Original magnification x60, bar = 50 μm. 
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Indeed viral N-protein could be detected in HEL cells inoculated with HTNV. 
Intriguingly, after induction of HEL cell differentiation with PMA, expression of viral 
N-protein in HTNV-infected HEL cell cultures was increased and more widespread. In 
contrast, both unstimulated and PMA-stimulated cell cultures inoculated with PHV or 
TULV remained negative for viral antigen. Confocal laserscan microscopy confirmed 
the presence of viral N-protein in the cytoplasm of HTNV-infected HEL cells (figure 
9A). In electron microscopy analysis HTNV-infected HEL cells showed the typical 
virus-induced intracytoplasmic granulofilamentous inclusion bodies (Figure 9B) that are 
closely associated with the rough endoplasmic reticulum (ER) and the ER-Golgi 
intermediate compartment (ERGIC) (Ramanathan et al., 2007). 
 
 
Figure 9: Analysis of HTNV-infected HEL cells by confocal laserscan- and electron microscopy.  
(A) PMA-stimulated HEL cells were stained with antibody directed against viral protein (green) three dpi. 
Cells were stained against viral N-protein using a rabbit-derived polyclonal antiserum (green) and 
filamentous actin using rhodamine labelled phalloidine (red). To localize the nucleus, DNA was stained 
with DAPI (blue), bar = 5 μm. (B) Unstimulated HEL cells were infected with HTNV and analysed by 
electron microscopy three dpi. Typical filamentous structures of viral N-protein were detected in the 
cytoplasm of the cell (black arrow), bar = 1μm. 
 
The growth pattern of HTNV in HEL cells was investigated in more detail. As 
shown in figure 10A HTNV replicated with moderate efficiency in undifferentiated HEL 
cells reaching titers of approximately 103 FFU/ml. Intriguingly, a switch from low-level 
to high-level virus production occurred after PMA-induced differentiation of HTNV-
infected HEL cells. The titers increased more than 100 fold and reached peak titers 
between 105 and 106 FFU/ml. Figure 10B shows immunofluorescence picture of 
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unstimulated and PMA-stimulated HTNV-infected HEL cells. The different pattern of 
infection can be clearly seen. This strong increase in virion production was observed 
although PMA-induced differentiation of HEL cells was associated with an arrest in 
proliferation (figure 15, p. 43). 
 
 
Figure 10: Infection and replication of HTNV in HEL cells.  
(A) Growth kinetics of HTNV in unstimulated and stimulated HEL cells. Cells were infected with HTNV 
at MOI 1.5. Virus was allowed to adsorb to cells for one hour and washed three times with cell culture 
medium. Afterwards cells were resuspended in medium at a concentration of 500,000 cells/ml. 
Stimulation with PMA (10 nM) was performed right after infection. Supernatant was harvested at 
indicated time points. Results show means ±1 SD (standard deviation) out of three independent 
experiments. (B) Immunofluorescence of HEL cells infected with HTNV in presence and absence of 
PMA. Cells were harvested three days pi. Viral nucleoprotein was visualized by using a rabbit-derived 
polyclonal antiserum against viral N-protein (green). Original magnification x60. 
 
Collectively, these data demonstrate that PMA-induced differentiation of HEL 
cells was associated with drastically upregulated release of HTNV virions. 
 
3.4.2 Switch to high-level HTNV replication independent from PMA-induced 
upregulation of the HTNV receptor 
Next we investigated whether PMA-induced upregulation of β3 integrin, the HTNV 
receptor on the surface of HEL cells, contributes to the switch to high-level HTNV 
replication after PMA treatment (figure 11A). After stimulation with PMA for one day, 
surface expression of β3 integrin is already increased on HEL cells. Therefore HEL 
cells were treated with PMA either one day before infection or directly after infection 
and virus titers were determined over time. Furthermore, it was analysed whether the 
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increased titers observed with HEL cells were due to stimulation of VeroE6 cells with 
residual PMA during titration. For this purpose, VeroE6 cells were infected with HTNV, 
stimulated with PMA, and supernatants were titrated (figure 11B). 
 
 
Figure 11: Titers of HTNV in HEL and in Vero E6 cells after PMA treatment.  
(A) Titers of HTNV in the supernatant of HEL cells three days pi without PMA stimulation, with PMA 
stimulation (10 nM PMA) directly after infection or with PMA stimulation one day before infection (10 
nM PMA). (B) Titers of HTNV in supernatant of VeroE6 cells three days pi without PMA stimulation or 
with PMA stimulation (10 nM PMA) directly after infection. ∗ p < 0.05. 
 
Stimulation of HEL cells with PMA prior to infection did not increase viral output 
as compared to HEL cells stimulated with PMA directly after infection. Moreover, PMA 
stimulation of VeroE6 cells did not influence HTNV replication. In conclusion, 
increased titers of HTNV in PMA-stimulated HEL cells are caused by a direct effect of 
PMA on HEL cells, which is independent of PMA-induced upregulation of β3, and not 
by an indirect effect on VeroE6 cells during titration.  
 
3.4.3 Infection of TF-1 cells  
TF-1 cells express markers of the erythroid as well as of the megakaryocytic lineage 
similar to HEL cells. TF-1 cells were infected with HTNV, TULV and PHV at MOI 1.5 
and analysed by immunofluorescence microscopy for infection (figure 12). 
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Figure 12: Immunofluorescence microscopy analysis of TF1 cells infected with HTNV, TULV and 
PHV.  
Unstimulated TF-1 cells were infected with hantavirus strains as indicated and stained for viral N-protein 
using a rabbit-derived polyclonal antiserum (green) three days pi. Nuclei were stained with DAPI (blue). 
Original magnification x60, bar = 50 μm. 
 
Similar to HEL cells viral N-protein was found in TF-1 cells after HTNV infection 
but not after infection with TULV and PHV.  
The growth pattern of HTNV in TF-1 cells was analysed in more detail. For this 
purpose, supernatant of HTNV-infected TF-1 cells were collected at different time 
points after infection and the titer was determined (figure 13).  
 
 
Figure 13: Growth kinetics of HTNV in TF-1 cells.  
TF-1 cells were infected with HTNV at MOI 1.5. Virus was allowed to adsorb to cells for one hour 
followed by three times washing with cell culture medium. Cells were seeded at a concentration of 
500,000 cells/ml. Supernatant was harvested at indicated time points and analysed by titration. Results are 
means ±1 SD derived from three independent experiments. 
 
The peak virus titer was observed three days after infection. Until day 8 pi the 
output of viral particles decreased by two logs and then stayed constant until 16 days pi.  
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3.4.4 Resistance of K562, Meg-01 and L8057 cells to hantavirus infection 
In addition to HEL and TF-1 cells further cell lines of the megakaryocytic lineage 
were used for infection experiments: the human megakaryocytic cell lines K562 and 
Meg-01 (described in 3.2) and, since rodents are natural reservoir hosts for most 
hantaviruses, the murine megakaryocytic cell line L8057. Cells were infected with 
HTNV at MOI 1.5 and analysed by immunohistochemistry for the presence of viral N-
protein three days pi (figure 14). 
 
 
Figure 14: Analysis of K562, Meg-01 and L8057 cells for infection with HTNV.  
Cells were infected with HTNV (MOI=1.5) and harvested three days pi. Cells were stained for viral N-
protein using a rabbit-derived polyclonal antiserum (green). Nuclei were visualized by staining with 
DAPI (blue). PMA-stimulated HEL cells were used as positive control. Original magnification x60, bar = 
50 μm. 
 
In neither of the human cell lines K562 and Meg-01, nor the murine cell line 
L8057 viral N-protein was detected. Moreover, titration of supernatants of all cell lines 
also did not reveal the presence of HTNV virions (data not shown). Collectively, these 
results indicate that K562 cells, Meg-01 cells and the murine cell line L8057 are not 
susceptible to HTNV infection. 
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3.5 Impact of HTNV on proliferation, survival, and function of differentiating 
megakaryocytic cells  
3.5.1 Proliferation and survival of HTNV-infected HEL cells  
Next it was investigated whether HTNV infection impairs proliferation and survival of 
differentiating megakaryocytic cells. For this purpose, PMA-treated HEL cells were 
used as they represent a well-established model of megakaryocyte differentiation (Long 
et al., 1990) and can be efficiently infected with HTNV. Counts of live unstimulated and 
PMA-stimulated HEL cells were determined after infection by trypan blue exclusion 
assay (figure 15). 
 
 
Figure 15: Proliferation and survival of mock- and HTNV-infected HEL cells.  
(A) Proliferation of HEL cells. HEL cells were seeded at a concentration of 200,000 cells/ml and counted 
at 1, 2, 3, 4 and 7 days post infections. The growth is given on the y-axis relative to the cell number at 
time point 0 (fold growth). (B) Survival of HEL cells. Dead cells were visualized with trypan blue and are 
given as the percentage of total cells. Results shown are means ±1 SD derived from three independent 
experiments.  
 
Cell growth of unstimulated HEL cells was not significantly inhibited after 
infection with HTNV. Stimulation of mock-infected HEL cells with PMA led to an 
arrest of proliferation, as described previously (Papayannopoulou et al., 1983). 
Intriguingly, despite of PMA-induced high-level virus replication (see figure 10, p. 39) 
no significant differences in proliferation and survival could be detected between mock- 
and HTNV- infected HEL cells. In proliferating untreated cells up to 20% dead cells 
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accumulated, whereas less than 5% dead cells were observed in PMA-stimulated cells 
that did not divide. However, the percentage of dead cells between mock- and HTNV-
infected HEL cells did not differ significantly. Taken together, these results demonstrate 
that HTNV does not alter proliferation and survival of differentiating megakaryocytic 
cells. 
 
3.5.2 Analysis of programmed cell death in HTNV- and mock-infected HEL cells 
Apoptosis, the programmed cell death, is part of the strongly regulated cellular 
metabolism. It is induced as innate response of the infected cell to eliminate the 
pathogen. Therefore, it was investigated whether HTNV induces apoptosis in untreated 
or PMA-treated HEL cells. For this purpose the TUNEL assay was used in which the 
enzyme terminal deoxynucleotidyl transferase labels 3’hydroxyl-DNA ends, generated 
during DNA fragmentation, with fluorescent dUTP. Thus, nicks in the DNA strand 
during apoptosis induction are visualized. HEL cells exposed to staurosporine, a 
microbial alkaloid that induces apoptosis in cell culture, served as a positive control 
(figure 16).  
Results 
 
Figure 16: TUNEL assay of mock-infected and HTNV-infected HEL cells.  
HEL cells were infected with HNTV (MOI 1.5) either stimulated with PMA (10 nM) (+PMA) or left 
unstimulated (-PMA) and analysed three days pi. As positive control HEL cells were treated with 
staurosporine (1μl/ml) over night. Cells were analysed for DNA degradation by TUNEL assay (green) 
and stained for viral N-protein using a rabbit-derived polyclonal antiserum (red). Nuclei were visualized 
with DAPI (blue). One representative out of three independent experiments is shown. Original 
magnification x60, bar = 50 μm. 
 
DNA degradation could be observed neither in mock- nor in HTNV-infected cells. 
Similarly, after stimulation with PMA no DNA strand brakes were detected. Thus, even 
high-level replication of HTNV does not induce apoptosis in HEL cells. 
 To confirm the results obtained with the TUNEL assay apoptosis in HEL cells 
was analysed by flow cytometry. Another typical sign of apoptosis and necrosis is the 
loss of the asymmetric structure of the cellular membrane. Thus, phosphatidylserine, a 
phospholipid component usually located on the cytosolic side of the membrane can be 
detected on the outer leaflet of the cell membrane of apoptotic cells. AnnexinV, a 
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member of the annexin protein family, binds to phosphatidylserine in a calcium-
dependent manner. HEL cells were infected with HTNV and treated with PMA or left 
untreated. Cells treated with staurosporine were used as positive control for apoptosis 
induction. After surface staining with AnnexinV cells were analysed by flow cytometry 
(figure 17).  
 
 
Figure 17: Flow cytometric analysis of apoptosis in mock-infected and HTNV-infected HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were either stimulated with PMA (10 nM) 
(+PMA) or left unstimulated (-PMA). As a positive control HEL cells were treated with staurosporine 
(1μl/ml) over night. Three days pi apoptosis was detected by staining with FITC AnnexinV. Grey filled 
curves represent negative control (unstained cells), blue open curves indicate mock-infected cells, red 
open curves represent HTNV-infected cells, and black open curves indicate positive control. On the x-axis 
fluorescence intensity, on the y-axis cell count is given. Data shown are representatives of three 
independent experiments. 
 
Only very few cells were stained with AnnexinV no matter whether mock- or 
HTNV-infected. Collectively these results clearly indicate that HTNV does not induce 
apoptosis in megakaryocytic cells. 
 
3.5.3 Endoreplication of HTNV-infected HEL cells after PMA-induced 
differentiation 
Differentiating megakaryocytes do not proliferate but further increase their ploidy by 
endoreplication (Odell & Jackson, 1968), the continued DNA synthesis without 
completion of mitosis and in the absence of cytokinesis. The separation process is 
initiated as usual: prophase, prometaphase, metaphase and anaphase I are performed. 
Subsequently, cells are arrested in anaphase I. As a consequence anaphase II, telophase 
and cytokinesis are neglected and the whole process is initiated again (Nagata et al., 
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1997; Schulze & Shivdasani, 2004). DNA content is increased up to 64n and nuclei 
become multilobulated. Thus analysis of DNA content can be used to analyse the 
progress of megakaryopoiesis.  
HEL cells undergo endoreplication after stimulation with PMA, similar to primary 
megakaryocytes. To test, whether infection interferes with endoreplication, analysis of 
DNA content was performed by staining cellular DNA with propidiumiodide. PI 
intercalates into nucleic acids and thus DNA content can be visualized. Results are 
shown in figure 18. 
 
 
Figure 18: DNA content in mock- and HTNV-infected HEL cells 7 days pi.  
(A) Dot blot analysis of DNA content of PMA stimulated (+PMA) and unstimulated (-PMA) HEL cells. 
On the x-axis PI fluorescence intensity, on the y-axis cell size is indicated. Gates mark different stages of 
DNA ploidy (n). (B) Histogram of DNA content in HEL cells. On the x-axis PI fluorescence intensity, on 
the y-axis relative number of cells is indicated. Mock-infected cells are shown in blue, HTNV-infected 
cells are shown in red. Results shown are representatives of four independent experiments. 
 
Figure 18A shows the HEL cells in the different stages of ploidy. It can be clearly 
seen, that stimulation with PMA induces endoreplication and an increased ploidy. No 
major differences were detected between mock- and HTNV-infected cells. Table 2 
demonstrates that no differences in percentages of cells in different stages are observed 
comparing mock- and HTNV-infected HEL cells.  
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Table 2: Percentage of HEL cells with different ploidy. Results shown are means derived from four 
independent experiments 
 mock-infected  
-PMA 
HTNV-infected 
-PMA 
mock-infected 
+PMA 
HTNV-infected 
+PMA 
2n 45.5 43.5 30.5 29.75 
4n 19 18 16 17 
8n - - 6 5.75 
16n - - 1.5 1.75 
 
In conclusion, these findings suggest that high-level HTNV replication does not 
interfere with endoreplication in differentiating HEL cells. 
 
3.5.4 Adhesive properties of HEL cells 
During megakaryopoiesis direct contact between megakaryocytic cells and the 
extracellular matrix is of great importance for cell growth, proliferation, differentiation 
and maturation of the cells. Therefore, the interaction of adhesion molecules and 
integrins with their ligands plays a crucial role in function and development of cells 
(Verfaillie, 1998; Whetton & Dexter, 1993) including megakaryocytes and their 
progenitors. Different kinds of adhesion receptors are known, like β1, β3 or cell 
adhesion molecules such as Inter-Cellular Adhesion Molecule 1 (ICAM-1, CD54).  
 
3.5.4.1 Expression of ICAM-1 on HEL cells 
ICAM-1 is a transmembrane protein of the immunoglobulin superfamily expressed on a 
variety of cells like monocytes, epithelial cells, leukocytes and megakaryocytes 
(Elangbam et al., 1997; Tanaka et al., 1996). It is involved in inter cell adhesion, 
binding to leukocyte function associated antigen (LFA-1), macrophage-1 antigen (Mac-
1), and fibrinogen (Diamond et al., 1993; Simmons et al., 1988). By binding to its 
ligands it triggers important immune functions: leukocyte-endothelial cell interaction 
and T-cell activation (Languino et al., 1993). Furthermore ICAM-1 is known to interact 
with several pathogens like rhinoviruses or Plasmodium falciparum (Berendt et al., 
1992; Greve et al., 1989). The expression of ICAM-1 on HEL cells, after infection with 
Results 
HTNV, was measured to investigate a possible influence of HTNV on adhesive 
properties of HEL cells (figure 19). 
 
 
Figure 19: Expression of ICAM-1 on HEL cells.  
Stimulated (+PMA) and unstimulated (-PMA) HEL cells were analysed by flow cytometry for ICAM-1 
expression. Grey filled curves represent isotype control, blue open curves show specific staining of mock-
infected cells and red open curves indicate HTNV-infected cells. Numbers in the upper right corner of the 
histograms represent mean fluorescence intensities. On x-axis fluorescence intensity, on y-axis cell count 
is indicated. Data shown are representatives of three independent experiments. 
 
No significant differences in ICAM-1 expression between mock- and HTNV-infected 
HEL cells were detected by flow cytometry. 
 
3.5.4.2 Adhesion of HTNV-infected HEL cells to extracellular ligands 
We further analysed whether HTNV replication interferes with adhesion of HEL cells to 
immobilized extracellular matrix ligands. For this purpose, fibrinogen was used as a 
ligand for αIIbβ3, fibronectin as a ligand for α5β1, and vitronectin as a ligand for αvβ3 
(figure 20). 
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Figure 20: Adhesion of mock- and HTNV-infected HEL cells to extracellular ligands.  
HEL cells were mock-infected or infected with HTNV (MOI 1.5). After three days of infection cells were 
allowed to adhere to extracellular ligands for 90 min. After washing off non-adhering cells, the number of 
cells adhering to ligands as indicated was calculated by MTT assay. Values represent means ±1 SD of 
triplicate determinations and are derived from three independent experiments. ∗ p < 0,05 
 
  After stimulation with PMA adhesion of HEL cells to fibronectin, vitronectin, 
and fibrinogen, was increased. Enhanced adherence after stimulation was observed with 
mock- and HTNV-infected cells, indicating that high-level replication of HTNV does 
not alter the adhesive properties of HEL cells.  
 
3.5.5 Antiviral innate immune response in HEL cells 
Any pathogen invading an organism has to cope with the innate immune system of the 
host. The innate receptors sensing pathogens are the pattern recognition receptors. Once 
pathogens are detected, an innate immune response is rapidly induced. 
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3.5.5.1 Expression of RIG-I in HEL cells 
The RIG-I protein, a cytoplasmic PRR sensing viral RNA, is stimulated by hantaviral 
RNA (Lee et al., unpublished data). Moreover, it was shown that the viral glycoprotein 
G1 (NYV) has an inhibitory effect on RIG-I signalling (Alff et al., 2006; Alff et al., 
2008) suggesting that pathogenic hantaviruses try to subvert RIG-I function. Hence, we 
analysed RIG-I expression in HEL cells after infection with HTNV by immunoblot 
(figure 21). 
 
 
Figure 21: Expression of RIG-I in HEL cells.  
Mock- and HTNV-infected HEL cells were treated with 10 nM PMA (+PMA) or left untreated (-PMA), 
harvested at 1-4 days pi as indicated, and analysed for RIG-I expression by immunoblot. β-actin was used 
as a loading control. One representative experiment out of three is shown. 
 
HTNV infection did not influence RIG-I expression. Surprisingly, a decreased 
expression of RIG-I was seen after stimulation of HEL cells with PMA irrespective of 
whether cells were mock-infected or HTNV-infected. These data suggest that PMA 
interferes with RIG-I expression in megakaryocytic cells.  
 
3.5.5.2 Expression of antiviral protein MxA in HEL cells 
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 The antiviral protein MxA, an interferon stimulated gene, inhibits replication of 
hantaviruses in cell culture (Frese et al., 1996; Kanerva et al., 1996). In addition Kraus 
et al. showed that MxA expression is decelerated in human umbilical vein endothelial 
cells (HUVECs) infected with highly virulent HTNV in contrast to HUVECs infected 
with the rather non-pathogenic TULV (Kraus et al., 2004). Therefore we decided to 
analyse MxA expression in HEL cells after infection with HTNV. First, we tested 
whether HEL cells are capable of expressing MxA and included TF-1 cells in this type 
of analysis. For this purpose cells were stimulated with IFN-α (figure 22).  
Results 
 
Figure 22: Expression of antiviral protein MxA in IFN-α stimulated HEL and TF-1 cells.  
HEL and TF-1 cells were stimulated with IFN-α (2000U/ml) over night. Cells were harvested and 
analysed by immunoblot for MxA expression. As positive control Huh7 cells stimulated with IFN-α 
(2,000 U/ml) were used. β-actin was used as a loading control. Lane 1: IFN-α stimulated HEL cells; lane 
2: IFN-α stimulated TF-1 cells; lane 3: IFN-α stimulated Huh7 cells (positive control, pc). One, out of 
two independent experiments is shown. 
 
Both HEL and TF-1 cells expressed MxA, although to a much weaker extend than 
Huh7 cells. TF-1 cells, as they showed less IFN-α induced MxA expression than HEL 
cells, were excluded from further analysis. Next, HEL cells were infected with HTNV 
and expression of MxA was analysed by immunoblot technique (figure 23). 
 
 
Figure 23: Expression of antiviral MxA in mock- and HTNV-infected HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left 
untreated (-PMA), harvested at 1-4 days pi as indicated, and analysed for expression of MxA and viral N-
protein by immunoblot. As a positive control (pc) Huh7 cells, stimulated with IFN-α (2,000 U/ml) over 
night, were used. β-actin served as a loading control. One representative out of three independent 
experiments is shown. 
 
Although capable of expressing MxA after stimulation with IFN-α, no MxA 
expression was detected after HTNV infection at any time point analysed. The same 
result was obtained with PMA-treated HEL cells despite of HTNV high-level 
replication in these cells. Altogether these results suggest that the antiviral MxA protein 
is not induced in HEL cells after infection with HTNV.  
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3.5.5.3 Analysis of RIG-I and MxA expression after exposure of HEL cells with 
TULV 
So far neither viral N-protein nor virion production could be detected in TULV-infected 
HEL cells. Nevertheless, HEL cells expressed the β1 integrin, a cellular receptor for 
TULV. Thus, it is possible that a rapidly induced innate immune response prevents 
TULV replication, although TULV might enter HEL cells. Consequently, we analysed 
MxA and RIG-I expression in TULV-infected HEL cells (figure 24). 
 
 
Figure 24: Analysis of MxA and RIG-I expression after exposure of HEL cells to TULV.  
TULV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left untreated (-PMA), 
harvested at 1-4 days pi as indicated, and analysed for expression of MxA and RIG-I by immunoblot. As a 
positive control (pc) Huh7 cells stimulated with IFN-α (2,000 U/ml) over night were used. β-actin served 
as a loading control. One representative out of three independent experiments is shown. 
 
No stimulation of MxA in HEL cells, neither in unstimulated nor in PMA-
stimulated, was observed after TULV infection. As described before (figure 21, p. 51) a 
decreased expression of RIG-I was seen after stimulation of HEL cells with PMA. 
Taken together, these findings indicate that, similar to HTNV, TULV does not induce the 
antiviral MxA protein in HEL cells. 
 
3.5.6 Analysis of β3-integrin in HTNV-infected HEL cells 
On one hand β3 is a protein that is upregulated during megakaryopoiesis and is 
important for megakaryocyte and platelet function, on the other hand β3 is a cellular 
receptor for entry of pathogenic hantaviruses. As HTNV uses β3 integrin as entry-
receptor for infection, expression of this receptor might be influenced on respective 
cells. Altered expression of CD61 could lead to a disturbed megakaryopoiesis and 
thrombopoiesis. Therefore, we analysed β3 expression in HEL cells by three different 
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techniques: (1) surface expression by flow cytometry, (2) overall expression by 
immunohistochemistry and (3) overall expression by immunoblot.  
 
3.5.6.1 Flow cytometric analysis of β3-integrin expression on HEL cells 
HTNV-infected HEL cells were analysed for β3 integrin expression by flow cytometry. 
To clarify, if there is a general effect on megakaryopoiesis after infection, the early 
megakaryopoiesis marker CD41 and late megakaryopoiesis marker CD42 were 
analysed in parallel (figure 25).  
 
 
Figure 25: Expression of megakaryopoiesis markers on mock- and HTNV-infected HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left 
untreated (-PMA), harvested 3 days pi, and analysed by flow cytometry for expression of CD41, CD61 
(β3 integrin) and CD42. Grey filled curves represent isotype control, blue open curves show specific 
staining of mock-infected cells and red open curves indicate HTNV-infected cells. On x-axis fluorescence 
intensity, on y-axis cell count is given. Numbers in the upper right corner of the histograms represent 
mean fluorescence intensities. Data shown are representatives of three independent experiments. 
 
On PMA-stimulated HEL cells CD41 expression was slightly increased whereas 
CD61 expression was strongly upregulated as described before (figure 6, p. 34). 
Expression of late megakaryopoiesis marker CD42 was observed neither on 
unstimulated nor on PMA-stimulated HEL cells. Upregulation of CD41 and CD61 after 
stimulation with PMA indicates that cells differentiate into mature megakaryocytes, but 
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as no expression of CD42 was detected, cells are at an early differentiation state. 
Importantly, no significant differences in expression of CD41 and CD61 between mock- 
and HTNV-infected cells were detected. Collectively, these data further illustrate that 
HTNV does not block differentiation of megakaryocytic cells despite of high-level 
replication.  
 
3.5.6.2 Immunohistochemical analysis of β3 in HEL cells 
Flow cytometric analysis revealed no differences in CD61 surface expression. However, 
we did not gain any information about intracellular expression. For this reason we 
analysed β3 expression by immunohistochemistry to assess both, its extra- and 
intracellular expression as well as its localization. As a control, expression of CD29, the 
receptor for non-pathogenic hantaviruses was determined (figure 26). 
 
Figure 26: Expression of β1 and β3 in mock- and HTNV-infected HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left 
untreated (-PMA) and harvested three days pi. Cells were stained for β1 or β3 integrin (green) and viral 
N-protein (red). Orange arrow demonstrates cells with strong β3 expression, yellow arrow depicts cells 
that hardly express β3. Original magnification x60. 
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Both unstimulated and PMA-stimulated HEL cells showed strong β1 as well as β3 
expression. No obvious differences were observed between mock- and HTNV-infected 
cells. Intriguingly, the merge of the staining for viral N-protein and β3 revealed that 
HEL cells strongly infected with HTNV hardly expressed any β3 (yellow arrow). Vice 
versa, in cells expressing high amounts of CD61 hardly any viral N-protein could be 
found (orange arrow). Whether this effect was due to downregulation or “masking” of 
CD61 by HTNV or whether HTNV preferably infects cells with lower CD61 expression 
remains to be investigated.  
 
3.5.6.3 Immunoblot analysis of β3 in HEL cells 
Finally, β3 expression of HEL cells was analysed by immunoblot to assess the total 
expression level of β3 integrin (figure 27).  
 
 
Figure 27: Analysis of β3 integrin in mock- and HTNV-infected HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left 
untreated (-PMA), harvested at 1-4 days pi as indicated, and analysed for expression of β3 integrin and 
viral N-protein by immunoblot. β-actin was used as loading control. One representative out of three 
independent experiments is shown. 
 
Analysis of β3 by immunoblot revealed a slightly decreased expression of β3 in 
HTNV-infected HEL cells after stimulation with PMA. At day 3 and 4 after infection 
expression is lower in HTNV-infected, PMA-stimulated cells as compared to mock-
infected, PMA-stimulated cells. Taken together, these results could imply that high-level 
HTNV replication downregulates intracellular β3 integrin late during infection of PMA-
treated HEL cells.  
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3.5.7 Internalisation of integrin β1 and β3 by HEL cells 
β1 and β3 integrins are not only receptors for hantaviruses, they are also important for 
many cellular processes like adhesion, migration, proliferation, apoptosis and 
phagocytosis (Caswell & Norman, 2006). Integrin-dependent migration and focal 
adhesion is a function of integrin recycling (Bretscher, 1992; Caswell & Norman, 2008; 
White et al., 2007). As integrins play a key role in megakaryocyte differentiation and 
migration we decided to analyse trafficking of β1 and β3 integrin in HTNV-infected 
HEL cells by internalisation assay. Results for both integrins are shown in figure 28. 
 
 
Figure 28: Internalisation assay of CD29 and CD61 on HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left 
untreated (-PMA). At 3 days pi cells were stained for CD29 (β1 integrin) or CD61 (β3 integrin) in culture 
medium for 1 h. After being washed twice, cells were incubated for 2 h at either 4°C (dark blue and dark 
red open curves) or 37°C (light blue and light red open curves). Subsequently, cells were stained for 
remaining cell surface-bound antibody with a secondary antibody. The reduction in specific staining at 
37°C compared to the specific staining at 4°C represents the level of internalisation. (A) Internalisation of 
CD29 (β1 integrin). On x-axis fluorescence intensity, on y-axis cell count is given. One representative 
experiment out of three is shown. (B) Statistical analysis of the percentage of CD29 (β1 integrin) 
internalisation. Values represent means ±1 SD and are derived from three independent experiments. (C) 
Internalisation of CD61 by HEL cells. On x-axis fluorescence intensity, on y-axis cell count is given. One 
representative experiment out of three is shown. 
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For unstimulated as well as for PMA-stimulated HEL cells a slight CD29 (β1 
integrin) internalisation (20-30%) was observed. But no significant differences between 
mock- and HTNV-infected cells could be shown as indicated in figure 28B. For β3 no 
internalisation could be detected. These data imply that HTNV does not interfere with 
trafficking of β1 integrin in HEL cells. Furthermore, expression of β3 integrin on HEL 
cells seems to be very stable as no internalisation was seen. 
 
3.5.8 Organization of filamentous actin in HEL cells 
The cytoskeleton is a cellular structure, consisting of several proteins and is important 
for cell shape, motility, transport, signal transduction and cell division. One of these 
proteins is actin, a monomeric protein. Actin monomers are composed as filaments, 
thereby forming the dynamic filamentous actin (F-actin). In megakaryocytes an intact 
cytoskeleton is important for the integrity of the cell and for the production of platelets 
(Baatout, 1996). For platelet formation an actin-dependent bending and bifurcation of 
the megakaryocyte is required (Italiano et al., 2007). Hence disturbance of actin 
organization after infection with HTNV could influence platelet formation and result in 
abnormal platelets. We analysed structure of F-actin by staining HEL cells with 
rhodamine labelled phalloidine and analysed by confocal laserscan microscopy. 
Phalloidine is a toxin isolated from the death cap and is known to bind to F-actin. 
Results are shown in figure 29. 
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Figure 29: Immunofluorescence staining of filamentous actin in HEL cells.  
Mock-infected and HTNV-infected (MOI 1.5) HEL cells were treated with 10 nM PMA (+PMA) or left 
untreated (-PMA). At three days pi HEL cells were stained with rhodamine labelled phalloidine to detect 
F-actin structures (red), viral N-protein was visualized using a rabbit-derived polyclonal antiserum 
(green), and DAPI to stain cellular nuclei (blue). Original magnification x60, bar = 50 μm. 
 
Staining with phalloidine showed an increase of F-actin structures after 
stimulation of HEL cells with PMA. However, neither for unstimulated nor for PMA-
stimulated cells differences between mock- and HTNV-infected cells were observed. In 
addition no colocalisation of viral N-protein with actin structures, as proved for Black 
Creek Canal virus, a new world hantavirus, was found (Ravkov et al., 1998). In 
conclusion, these findings indicate that despite of high-level replication HTNV does not 
impair the cytoskeleton of differentiating megakaryocytic cells. 
 
3.6 Interaction of HTNV with human platelets 
Despite differences in their clinical appearance all hantavirus-associated syndromes 
have in common an increased microvascular permeability as well as platelet dysfunction 
and a dramatic decrease in platelet count (acute thrombocytopenia), which marks the 
beginning of vascular leakage and the hypotensive phase (Schonrich et al., 2008). 
Platelets are anuclear cellular fragments that arise from megakaryocytes by cytoplasmic 
fragmentation. After release of the proplatelet into the blood biogenesis of platelets is 
continued in peripheral blood, mainly in the capillary bed of the lung (Behnke & Forer, 
1998; Junt et al., 2007), the first site of infection with HTNV. After release of platelets, 
cells circulate in the blood 7-10 days. 
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In general acute thrombocytopenia can be triggered by two mechanisms: (1) 
decreased production of platelets due to abnormal megakaryopoiesis/thrombopoiesis 
and (2) degradation of platelets in peripheral blood. Although we observed high-level 
replication of pathogenic HTNV in differentiating HEL cells, no direct virus-associated 
effect on phenotype and function could be detected in this well-established model 
system of megakaryopoiesis. Therefore, we decided to analyse the interaction of HTNV 
with platelets. 
First it was analysed whether platelets can be infected with HTNV. Platelets were 
isolated from healthy donors and analysed for infection 24 h pi by 
immunohistochemistry. However, viral proteins were not detectable in human platelets 
by immunohistochemistry and supernatants of “infected” platelets did not contain 
virions (data not shown). 
 
3.6.1 Analysis of HTNV-induced platelet activation 
Although viral replication could not be demonstrated, it was nevertheless possible that 
HTNV interferes with platelet function. Resting platelets, circulating in the 
bloodstream, become activated after damage of the endothelial barrier. Several receptors 
are upregulated, platelets adhere and aggregate, and lesions are sealed. Activation 
marker CD62P (P-selectin) is stored in α-granules and transported to the cell surface 
after activation and several plasma proteins (e.g. platelet factor 4) are released (Kaplan 
et al., 1979). We analysed platelet activation to verify whether hantaviruses bind to β3 
integrin or further receptors and thus induce uncontrolled activation resulting in platelet 
exhaustion. For this purpose, platelets were isolated from healthy donors and analysed 
for activation by flow cytometry. Platelets stimulated with thrombin were used as a 
positive control. The results are shown in figure 30. 
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Figure 30: Flow cytometric analysis of platelets for activation marker CD62P.  
Freshly isolated platelets were exposed to HTNV at MOI 0.1 and analysed for CD62P expression by flow 
cytometry 24 h pi. Grey filled curves indicate isotype control, the blue open curve represents mock-
infected cells, the red open curve shows HTNV-exposed platelets and the black open curve shows 
platelets stimulated with thrombin (pc = positive control). On x-axis fluorescence intensity, on y-axis cell 
count is given. Mean fluorescent intensities are shown in the upper right corner of each histogram. One 
representative experiment out of three is shown. 
 
No activation of platelets after exposure to HTNV was observed. The slight 
activation on mock-infected and HTNV-exposed platelets is probably caused by the 
isolation procedure. Collectively, these experiments indicate that HTNV does not trigger 
uncontrolled activation, which could result in “exhaustion” of platelets. 
 
3.6.2 Interference of HTNV with essential adhesion molecules on platelets  
Next to activation markers integrins αIIbβ3 (CD41/CD61), αvβ3 (CD51/CD61) and 
CD42 (complex of CD42 a, b, c, d) are important for platelet aggregation and 
attachment to diverse matrix proteins. αIIbβ3 binds to various RGD sequence 
containing peptides e.g. fibrinogen, fibronectin, van Willebrand factor and 
thrombospondin. Similarly, αvβ3, also called vitronectin receptor binds to RGD binding 
peptides like vitronectin and van Willebrand factor. The CD42 complex is a receptor for 
van Willebrand factor and thrombin. Platelets were isolated from healthy donors, 
“exposed” to HTNV and analysed by flow cytometry for CD61, CD41 and CD42 
(figure 31).  
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Figure 31: Expression of CD61 on mock-infected platelets and platelets exposed to HTNV.  
Freshly isolated platelets were “infected” with HTNV at MOI 0.1 and analysed for expression of CD61, 
CD41 and CD42 by flow cytometry 24 h pi. (A) Histograms of flow cytometry analysis. Grey filled 
curves indicate isotype control, the blue open curve shows mock-infected cells, the red open curve 
represents platelets exposed to HTNV. Mean fluorescent intensities are shown in the upper right corner of 
histograms. One representative experiment out of 8 is shown. (B) Box-Whisker plots of mean 
fluorescence intensity (MFI) of CD61, CD41 and CD42 surface expression on mock-infected and HTNV-
exposed platelets. CD61: n=8, CD41: n=7, CD41: n=7, ∗ = p < 0.05. 
 
Analysis of CD61, CD41 and CD42 showed a significant downregulation on the 
surface of platelets 24 h after exposure to HTNV. Strongest decrease in expression was 
observed for CD61. Receptors analysed are important for adhesion and aggregation of 
platelets after injury of the endothelial barrier. Collectively, these results suggest that 
HTNV may interfere with phenotype and function of platelets. 
 
3.7 Activation of human lymphocytes after exposure to HTNV 
After hantavirus infection in humans a vigorous antiviral T-cell response is induced. 
CD8+ virus-specific cytotoxic T-cells directed against viral N-protein are generated 
(Van Epps et al., 2002) and the CD8/CD4 T-cell ratio is inverted (Huang et al., 1994). 
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Severity of disease seems to correlate with the frequency of virus-specific CTLs, as it 
was shown that patients suffering from severe symptoms after SNV infection had higher 
frequencies of SNV-specific T-cells than patients with less severe symptoms (Kilpatrick 
et al., 2004). After hantavirus infection long-term T-cell memory develops, although 
there is no sign of virus persistence (Van Epps et al., 2002). To further analyse the role 
of lymphocytes in hantavirus infection PBMCs from buffy coats were isolated, infected 
with HTNV and analysed for activation marker CD69. Results are shown in figure 32.  
 
 
Figure 32: Analysis of lymphocytes for activation marker CD69 after infection with HTNV.  
PBMCs isolated from blood of healthy donors were infected with HTNV (MOI 1.0) and analysed for 
expression of CD69 at three days pi by flow cytometry. (A) Dot plots of flow cytometry analysis. The y-
axis indicates cell size, the x-axis shows expression of CD69. In the upper right corner the percentages of 
CD69-positive cells are given. One representative experiment out of seven is shown. (B) Box-Whisker 
plot of statistical analysis of CD69 expression on mock- and HTNV-infected lymphocytes. ∗ = p<0.05, n 
= 7. 
The activation marker CD69 was upregulated on a significant proportion of 
lymphocytes after HTNV infection. In conclusion, these findings suggest that HTNV 
can activate lymphocytes derived from healthy donors in vitro efficiently.  
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3.8 HTNV-induced changes in survival, phenotype, and function of human 
monocytes 
3.8.1 HTNV-induced survival of monocytes 
Some subpopulations of monocytes, the precursor cells of both macrophages and 
myeloid dendritic cells, are known to be susceptible to hantaviruses (Markotic et al., 
2007). Next to its role as precursor cells, monocytes are important immune cells. They 
phagocytose pathogens and are involved in antigen presentation. We wanted to test the 
effect of HTNV on monocytes. Therefore, monocytes isolated from buffy coats that had 
been derived from healthy donors were infected with HTNV and analysed by flow 
cytometry for apoptosis (figure 33).  
 
 
Figure 33: Analysis of apoptosis in mock- and HTNV-infected monocytes.  
Monocytes were isolated from peripheral blood mononuclear cells derived from healthy human donors by 
using the Monocytes Isolation KitII from Miltenyi Biotec. Mock- and HTNV- infected (MOI 1.0) 
monocytes were analysed for apoptosis by AnnexinV-staining three days pi. The x-axis depicts AnnexinV-
staining, the y-axis shows cell size of monocytes. One, out of two independent experiments is shown. 
 
As described previously mock-infected monocytes underwent apoptosis after 
isolation and culturing for some days (Keisari, 1996). Accordingly, these cells showed 
the morphology of dying cells, when analysed by light microscopy (data not shown). In 
striking contrast, HTNV-infected monocytes survived and only a low percentage of cells 
could be stained with AnnexinV. Additionally, the HTNV-cells had the morphology of 
live cells. In conclusion, HTNV infection enables monocytes to survive in cell culture. 
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3.8.2 HTNV-driven differentiation of monocytes  
Having established that HTNV-infection allows human monocytes to survive they were 
analysed by flow cytometry for expression of typical markers of monocytes and 
dendritic cells. However, as monocytes die off soon after a short period of culturing 
mock-infected monocytes were analysed right after isolation for comparison. The 
following proteins were analysed as marker molecules: CD14, a GPI-anchored 356 
aa glycoprotein expressed on monocytes and macrophages; CD83, a single-chain type-1 
glycoprotein expressed on mature myeloid DCs; CD86, a protein belonging to the 
immunoglobulin family, constitutively expressed on DCs and in low levels on 
monocytes; and DC-SIGN, a 404 aa glycoprotein that is predominantly expressed on 
dendritic cells. Results are shown in figure 34.  
 
Figure 34: Flow cytometric analysis of uninfected and HTNV-infected monocytes.  
(A) Monocytes were infected with HTNV (MOI 1) and analysed three days pi by flow cytometry for 
CD14, CD83, CD86 and DC-SIGN (red open curves). For comparison surface expression of uninfected 
monocytes (d0) is shown (blue open curves). Grey filled curves represent isotype controls. The x-axis 
shows staining with specific antibody, the y-axis indicates cell count. One representative experiment out 
of three is shown. (B) Box-Whisker plot of statistical analysis of expression of CD83 and DC-SIGN on 
mock-infected and HTNV-infected monocytes. ∗ = p<0.05, n= 3. 
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Flow cytometric analysis of monocytes showed that HTNV-infected monocytes 
lose their classical monocytic expression profile. Expression of CD14 hardly changed, 
but upregulation of macrophage/dendritic cell markers CD83, CD86, and DC-SIGN was 
detected. Upregulation of CD83 and DC-SIGN was shown to be significant. 
Collectively, these data demonstrate that HTNV induces differentiation of infected 
monocytes towards a cell type resembling macrophages/DCs. 
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4  Discussion 
In order to understand the mechanisms of hantaviral pathogenesis, until now research 
was focused on mechanisms which directly damage the endothelial barrier resulting in 
haemorrhages. However, in a healthy person microvascular lesions occur daily, but 
remain undetected as long as enough and fully functional platelets are available. Thus 
bleedings are prevented. As soon as platelets are defect and/or platelet count is too low, 
lesions cannot be sealed anymore and haemorrhages may appear. During hantavirus 
infection not only damage of the endothelial barrier but reduced platelet count and 
platelet dysfunction play a pivotal role (Cosgriff, 1991b). This suggests an involvement 
of cells of the haemostatic system in hantavirus pathogenesis. In this thesis the 
hantavirus-induced mechanisms leading to acute thrombocytopenia and platelet 
dysfunction were analysed. Moreover, the interactions of hantaviruses with cells of the 
human immune system were investigated as there is evidence that the immune system 
itself contributes to hantavirus-associated pathogenesis (immunopathogenesis). 
 
4.1 Megakaryocytic cells as a tool for studying megakaryopoiesis 
Megakaryopoiesis is the development of a haematopoietic stem cell into mature 
megakaryocytes. This process takes place via several steps of maturation and 
differentiation in the bone marrow. The percentage of megakaryocytes ranges from 
0.03% to 0.06% of all nucleated cells in the bone marrow (Saito, 1997), hence isolation 
of a large number for biochemical analysis is hardly possible. Furthermore ex vivo 
differentiation of CD34+ cells, isolated from umbilical cord blood, is very complex and 
difficult. Cells require special cytokine cocktails (e.g. TPO, stem cell factor, interleukin 
(IL) 1) to survive and developing megakaryocytes react sensitively to any change of 
condition (e.g. temperature, medium concentration) (Maurer et al., 2000). Thus working 
with primary megakaryocytes is complex, expensive and the yield of cells is usually 
very low. 
Therefore megakaryocytic cell lines, established from blood or bone marrow of 
patients with leukemia represent a precious alternative for analysing features of 
megakaryocytic cells. Cells are easy to maintain in culture and can be expanded to the 
desired number. They have no or little variation and are not as cost-intensive as primary 
cells. However one has to keep in mind that many megakaryocytic cell lines share 
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multilineage features, holding characteristics of erythroid, myeloid and megakaryocytic 
cells. Nevertheless these cell lines represent an excellent tool for studying 
megakaryopoiesis (Saito, 1997). 
 
4.2 Hantaviruses and megakaryocytic cells 
4.2.1 Susceptibility of megakaryocytic cells to hantavirus infection  
In this thesis, established megakaryocytic cell lines were tested whether they can be 
infected with hantaviruses. For the first time, we showed that pathogenic but not 
apathogenic hantaviruses target megakaryocytic cells. HTNV infected TF-1 and HEL 
cells in contrast to apathogenic PHV and TULV. Further human megakaryocytic cell 
lines (K562, Meg-01) and a murine megakaryocytic cell line (L8057) could not be 
infected with any hantavirus tested. TF-1 cells represent very undifferentiated cells 
(Kitamura et al., 1989). K562 and HEL cells are early megakaryoblast-like cells 
(Gewirtz et al., 1982; Papayannopoulou et al., 1988; Papayannopoulou et al., 1983; 
Saito, 1997), whereas HEL cells express more typical megakaryocytic markers. K562 
cells only commit towards the megakaryocytic lineage after stimulation with PMA and 
hold less megakaryocytic characteristics than HEL cells. Meg-01 cells represent a later 
stage, approximately the late megakaryoblast (Ogura et al., 1985; Takeuchi et al., 1991). 
Altogether, it seems that HTNV only infects cells of the early stage of 
megakaryopoiesis. 
Infection of megakaryocytic cells in the bone marrow of humans could influence 
megakaryopoiesis at different stages. This could result in defective megakaryocytes, 
less platelet production or “abnormal” platelets that have lost their functions. Several 
viruses are known to infect megakaryocytes and thus cause decreased platelet 
formation, e.g. human immunodeficiency virus (HIV) (Scaradavou, 2002; Zucker-
Franklin & Cao, 1989) and dengue virus (Basu et al., 2008). For HIV it is known that 
both reduced platelet production due to bone marrow suppression and the production of 
anti-platelet antibodies in peripheral blood contribute to virus-associated 
thrombocytopenia (Scaradavou, 2002). Thrombocytopenia is an important event in 
hantavirus-induced pathogenesis. Reduced platelet count may develop by decreased 
formation of platelets and/or increased elimination of platelets. Thus interaction of 
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hantaviruses with megakaryocytes and/or platelets could explain hantavirus-associated 
thrombocytopenia.  
 
4.2.2 Expression of hantavirus receptors on megakaryocytic cells 
The megakaryocytic cell lines TF-1, HEL, K562 and Meg-01 cells express β1-integrin 
(CD29), β3-integrin (CD61) and CD55/DAF, which facilitate hantavirus entry 
(Gavrilovskaya et al., 1999; Gavrilovskaya et al., 1998; Krautkramer & Zeier, 2008). 
However, we could hardly detect surface expression of gC1qR, which has been reported 
to enhance entry of HTNV infection into human lung epithelial A549 cells (Choi et al., 
2008), on any cell line analysed. Thus, except of unstimulated K562 cells, which do not 
express surface β3, all cell lines analysed were equipped with canonical hantavirus 
receptors, but only TF-1 and HEL cells were infectable. This observation suggests that 
besides the known surface receptors, hantavirus infection is dependent on additional 
factors. Possibly a hitherto unknown coreceptor is required for infection with 
apathogenic and/or pathogenic hantaviruses that is missing on some of the cells 
analysed. Alternatively, as integrins exist in various splice variants, it is possible that 
hantaviruses only use one special variant of the integrin, not expressed on all cell lines 
tested in this thesis (Fornaro & Languino, 1997; Svineng et al., 1998). HTNV only 
enters the cell when β3 is expressed in its inactive (bent) conformation (Raymond et al., 
2005). Thus, infection can only happen when β3 is not activated. Moreover, it is 
possible that viral particles enter the cells but do not replicate because the cellular 
milieu lacks certain proteins that are necessary to start the replication process. Finally, it 
has to be considered that a cell autonomous defence mechanism actively blocks viral 
replication.  
In summary, productive infection relies on several conditions that might not be 
given in all megakaryocytic cell lines tested and the fact that highly pathogenic HTNV 
but not less pathogenic TULV and PHV could establish infection in megakaryocytic 
cells, points towards an important role of this cell type in HFRS and possibly HCPS.  
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4.2.3 Switch to High level hantavirus replication after PMA treatment 
Stimulation of HEL cells with PMA increased hantavirus titers up to two logs. Although 
hantavirus receptor (β3) surface expression is increased after stimulation, the PMA-
induced upregulation does not explain increased titers, as stimulation with PMA before 
and after infection resulted in similar titers. It is possible that stimulated HEL cells 
provide better conditions for virus growth, such as increased availability of the ER-
Golgi intermediate compartment, which is required for hantaviruses replication 
(Ramanathan et al., 2007), or an enhanced nucleotide metabolism. However, PMA 
stimulation of HTNV-infected VeroE6 cells did not increase virus titers suggesting that 
PMA stimulates a pathway that is not affected or absent in these cells. For example 
PMA could have an inhibitory effect on induction of type I IFN or type I IFN signalling 
which is not obvious in VeroE6 cells that lack IFN type I genes (Diaz et al., 1988). 
Hantaviruses trigger IFN I and thereby the innate immune response. Thus, increased 
viral replication due to stimulation with PMA could be caused by an indirect effect: a 
diminished innate immune response. This finding is supported by the fact that 
expression of innate cytoplasmic sensor RIG-I is decreased after stimulation with PMA 
(figure 21, p. 51). It was shown that RIG-I senses viral N-protein encoding hantaviral 
RNA (Lee et al., unpublished data) and is a target of hantaviral immune evasion 
mechanisms (Alff et al., 2006). Type I IFN is triggered through RIG-I signalling, which 
binds to type I IFN receptor. Subsequently the receptor-associated tyrosine kinases janus 
protein tyrosine kinase 1 (JAK1) and tyrosine kinase 2 (TYK2) are activated resulting in 
posphorylation of signal transducer of activation and transcription (STAT1) and STAT2. 
These dimerize and translocate into the nucleus inducing transcription of multifarious 
genes, which subsequently induce transcription of a multitude of IFN-stimulated genes 
encoding antiviral effector components (Sadler & Williams, 2008) e.g. double-stranded 
RNA-dependent protein kinase (PKR) (Stark et al., 1998). 
Previously PMA has been shown to target components of the innate immune 
system. Inhibition of IFN-α stimulated tyrosine phosphorylation of transcription factors 
STAT1α, STAT2, STAT3 and TYK2 was shown after treatment of primary monocytes 
with PMA. Hence, PMA stimulation of monocytes resulted in inhibition of JAK/STAT 
pathway (Petricoin et al., 1996). Furthermore, PMA is known to activate the 
RAS/MAPK (mitogen-activated protein kinases) pathway (Marquardt et al., 1994), 
which controls many biological processes. For example, activated RAS inactivates 
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PKR, an important player of the antiviral innate immune response (Mundschau & 
Faller, 1992). For vesicular stomatitis virus (VSV) (Battcock et al., 2006), reovirus 
(ReoV) (Strong et al., 1998), herpes simplex virus type 1 (HSV1) (Farassati et al., 
2001) and ebola virus (EBOV) (Strong et al., 2008) it was demonstrated that virus 
growth is enhanced in RAS-transformed fibroblasts, showing that downregulation of 
antiviral innate immune responses induced by type I IFN increases viral replication. 
Altogether, PMA could enhance replication of hantaviruses through modulation of 
several key pathways including the RIG-I pathway, the JAK/STAT pathway and the 
RAS/MAPK pathway, which are shown in figure 35. 
 
 
Figure 35: Simplified schemes of cellular pathways influenced after PMA stimulation.  
(A) RIG-I pathway, (B) JAK/STAT pathway and (C) RAS/MAPK pathway 
 
Intriguingly, the PMA-associated effects could also be relevant in vivo as 
thrombopoietin, the central regulator for megakaryopoiesis in vivo, activates 
RAS/MAPK signalling (Kirito & Kaushansky, 2006). Thus, TPO-induced 
megakaryocyte differentiation in vivo could be linked to enhanced replication of 
hantaviruses in megakaryocytic cells (figure 37, p. 77).  
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4.2.4 Unaltered phenotypic and functional differentiation of HTNV-infected 
megakaryocytic cells despite high-level HTNV replication 
PMA-treated HEL cells represent a well-established model system of megakaryocyte 
differentiation. After PMA-treatment HEL cells stop proliferating and further 
differentiate into cells resembling more mature megakaryocytes, indicated by an 
increase in cytoplasm, ploidy and upregulation of megakaryocyte/platelet proteins 
(Long et al., 1990). Therefore, we analysed in detail whether the switch to high-level 
HTNV replication in HEL cells interfered with their differentiation. Only a slight but 
not significant reduction in proliferation of unstimulated HTNV-infected HEL cells was 
observed. Importantly, independent of whether HEL cells were HTNV-infected or 
mock-infected, PMA stimulation yielded in arrest of proliferation, begin of 
differentiation and initiation of endoreplication, an important step in megakaryocyte 
development. In addition no signs of HTNV-induced cell death, neither by analysis of 
DNA strand brakes, nor by staining with AnnexinV were seen.  
Adhesion of megakaryocytes to the extracellular matrix and among each other is 
an essential process during megakaryopoiesis. When cells were analysed for expression 
of adhesion molecule ICAM-I and for adhesion to components of the extracellular 
matrix, no differences were detected between mock and HTNV-infected cells. Integrin-
dependent migration and adhesion is closely connected to integrin recycling (Caswell & 
Norman, 2006) and disturbance in integrin trafficking could influence megakaryocyte 
development and function. Therefore, internalisation capacities of β1 and β3 were 
analysed. However, no significant differences were found between mock and HTNV 
infected HEL cells. Taken together, high level replication of HTNV did not interfere 
with proliferation, viability, adhesion and endoreplication of megakaryocytic cells. 
Megakaryocyte differentiation is accompanied by consecutive upregulation of 
surface expression of key markers CD41 (IIb integrin), CD61 (β3 integrin) and CD42. 
After HTNV infection no differences were observed in surface expression of these 
differentiation markers as compared to mock-infected cells. Intriguingly, 
immunofluorescence analysis localized HTNV preferably in HEL cells with low or no 
β3 expression. In contrast, cells with strong β3 expression were mostly uninfected. 
Thus, it was possible that HTNV downregulates β3 expression. To further examine this 
aspect we performed immunoblot analysis of β3 integrin 1-4 dpi. We found that overall 
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expression of CD61 was only slightly decreased over time in PMA-stimulated HEL 
cells after infection. This indicates that HTNV has only a weak influence on overall 
cellular β3 expression. It appears unlikely that HTNV “masks” the β3 integrin, e.g. by 
changing the conformation recognized by the anti-β3 antibody, as FACS analyses of 
HTNV-infected cell cultures using the same reagent revealed unaltered β3 surface 
expression. It is more likely that HTNV preferably infects cells with lower CD61 
expression, which represent more early stages of megakaryocyte differentiation. 
Supporting this view, HTNV infects TF-1 and HEL cells, but not Meg-01 cells. 
Moreover, upregulating β3 on HEL cells before infection by PMA treatment did not 
further increase viral replication as compared to cells that were treated with PMA 1 h 
after infection. In conclusion, HTNV seems to target early stages of megakaryocytes 
without causing any alteration in their further differentiation. 
 
4.2.5 Unaltered cytoskeleton in megakaryocytic cells after HTNV infection 
For BCCV colocalization of viral N-protein and F-actin in VeroE6 cells was detected 
and a role of actin in viral assembley was assumed (Ravkov et al., 1998). In contrast, for 
HTNV, it was shown that N-protein associates with microtubules, but not with actin in 
VeroE6 cells (Ramanathan et al., 2007). After analysis of F-actin and HTNV 
nucleoprotein in HEL cells by immunohistochemistry no alterations in cellular F-actin 
structures and no strong colocalization could be shown. This finding further supports 
the view that HTNV does not interfere with cytoskeletal structures of megakaryocytes 
and, as an intact cytoskeleton is essential for megakaryopoiesis and platelet formation, 
with megakaryopoiesis.  
 
4.2.6 Immunological aspects of HTNV infection of megakaryocytic cells 
The hantaviral N-protein is the most abundant viral protein and a strong immune 
response is directed against it in humans. It induces early IgM response and is known to 
interact with several cellular proteins (Kaukinen et al., 2005), e.g. actin filaments 
(Ravkov et al., 1998), the death-domain associated protein Daxx, a protein that 
interferes with various further cellular proteins (Li et al., 2002; Salomoni & Khelifi, 
2006), ubiquitin-like modifier-1 (SUMO-1) (Maeda et al., 2003), and antiviral MxA 
(Khaiboullina et al., 2005). Differentiating megakaryocytes could contribute to the 
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induction of a strong immune response against HTNV by releasing high numbers of 
virions containing protein.  
No expression of MxA was detected in unstimulated or PMA-stimulated HTNV-
infected HEL cells. Possibly, HTNV subverted the type I IFN-induced immune response 
in unstimulated HEL cells. Alternatively, low-level replication in unstimulated HEL 
cells was not able to trigger type I IFN production. In contrast, lack of MxA expression 
in PMA-stimulated HEL cells might be due to general inhibition of the type I interferon 
pathway by PMA.  
No cytopathic effect, even after stimulation of high-level replication, was found in 
HTNV-infected megakaryocytic cells. This suggests that thrombocytopenia occurs 
partly due to elimination of megakaryocytic cells by CTLs. In line with this view the 
density of human leukocyte antigen (HLA) class I molecules on HTNV-infected cells is 
upregulated (Pritesh Lalwani, personal communication) thereby most likely increasing 
the vulnerability to antiviral CTL attack. The aspect is supported by the fact that the 
frequency of virus-specific CTLs correlates with the severity of disease in HCPS 
patients (Kilpatrick et al., 2004). This implicates that more widespread infection of 
megakaryocytes renders more megakaryocytes susceptible to CTL attack resulting in a 
more drastic drop in platelet count. Indeed, analysis of blood showed that in patients 
suffering from NE or HCPS high viral loads correlate with low platelet count 
(Kilpatrick et al., 2004; Rasche et al., 2004; Terajima et al., 1999). Moreover, it was 
observed that immunosuppressive corticosteroid therapy, which suppresses CTL 
responses, increases platelet count in NE patients (Dunst et al., 1998; Seitsonen et al., 
2006) and in patients suffering from less severe HFRS a high frequency of virus-
specific T-cells producing IFN-γ has been observed (Wang et al., 2009). IFN-γ controls 
viral spread through non-cytolytic clearance avoiding excessive elimination of infected 
cells (Guidotti & Chisari, 2001). Altogether it seems that the immune system and not 
inhibition of megakaryopoiesis after infection contributes to thrombocytopenia. 
 
4.3 Interaction with platelets 
Besides a dramatic decrease in platelet count at the beginning of vascular leakage and 
the hypotensive phase, platelet dysfunction has been reported in patients with 
hantavirus-associated syndromes (Cosgriff, 1991a; Cosgriff et al., 1991b; Lee, 1987; 
Discussion 
 75
Lee et al., 1983). The hantavirus receptor β3 is expressed at a high density on platelets, 
where it has essential functions in processes like adhesion, migration and signalling 
(Shattil, 1995). On unactivated, circulating platelets β3 is expressed in its bent 
conformation, the conformation that pathogenic hantaviruses use for cell entry 
(Raymond et al., 2005).  
We could not detect HTNV infection of platelets in vitro, but recently it was 
detected that pathogenic hantaviruses bind to quiescent platelets (Gavrilovskaya et al., 
2010). Susceptibility of platelets to HTNV infection is unlikely anyway as hantavirus 
growth requires the ER-Golgi intermediate compartment (Ramanathan et al., 2007). In 
addition, no activation of platelets via P-selectin (CD62P) was seen after exposure of 
platelets to HTNV. However, surface markers CD61, CD41, and CD42 were 
downregulated 24 h after exposure of platelets to HTNV. This suggests that after contact 
of HTNV with integrin receptors on platelets signalling is induced, resulting in 
downregulation of adhesion markers. This implies loss of platelet function and reduced 
clotting capacities. Though, it is difficult to prove loss of coagulation capacities, due to 
experimental limitations in L3 biosafety level. Supporting our finding, Cho et al. found 
that expression of van Willebrand receptor (CD42) is reduced up to 86 % after HTNV 
infection of human umbilical vein endothelial cells possibly delaying coagulation (Cho 
et al., 2007).  
Patients who develop hemorrhagic fever suffer from bleedings, thrombocytopenia, 
coagulopathy and disseminated intravascular coagulation (Lee et al., 1989; Lee et al., 
1983). These bleedings resemble those found in Glanzmann’s disease, an inherited 
bleeding disorder, suggesting common causes (Gavrilovskaya et al., 2008; Raymond et 
al., 2005). On platelets of those patients αIIbβ3 is absent or dysfunctional, caused by 
mutations in genes of respective proteins. This leads to decreased ability of platelets to 
aggregate and thereby to defects in primary haemostasis (Nurden, 2006). We found 
decreased CD61 expression on platelets exposed to HTNV, which could substantially 
contribute to platelet dysfunction observed in patients with HFRS (Cosgriff, 1991a; 
Cosgriff et al., 1991b; Lee, 1987; Lee et al., 1983). In Glanzmann’s thrombasthenia 
patients who suffer from acute bleedings are treated with platelet transfusions (Bellucci 
& Caen, 2002). This therapy could help to prevent strong decrease in platelet count in 
patients with severe symptoms after hantavirus infection (Dietl et al., 2008; Kim et al., 
2003) and thus avert further fatal symptoms. 
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4.4 Interference of pathogenic Hantaviruses with the haemostatic system 
HTNV infects cells that are early stages of megakaryopoiesis. Furthermore HTNV 
interacts with platelets without infecting these cells. This Interaction leads to decreased 
expression of adhesion markers CD61, CD41 and CD42 on the platelet surface. 
 
 
Figure 36: Cells of the haemostatic system as targets for HTNV.  
Thin arrows demonstrate sites of interaction between virus and cells. Pathogenic HTNV infects the early 
megakaryoblast and interacts with platelets in humans. 
 
Taken together, our data provide evidence for two different mechanisms by which 
pathogenic hantaviruses interfere with haemostasis and exploit megakaryopoiesis to 
produce virions (figure 36). Firstly, HTNV infects megakaryocytic cells that resemble 
early megakaryoblasts without causing any obvious cytopathic effect. Infected 
megakaryocytic cells present hantaviral antigens in the context of HLA class I 
molecules, which are likely targets for CTLs. This could lead to reduced platelet 
production and acute thrombocytopenia. As a compensatory response the bone marrow 
increases megakaryopoiesis to counteract the low platelet count. In this way the pool of 
megakaryocytic cells susceptible to virus infection is enlarged, further enhancing the 
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virus load. The process is demonstrated in figure 37. In humans the virus is finally 
eliminated by a strong immune response. 
 
 
Figure 37: Regulation of megakaryopoiesis in a healthy and a HTNV-infected person.  
In a healthy person TPO expression is constant and regulates formation of megakaryocytes and platelets. 
An autoregulatory loop controls this process. In a hantavirus-infected person numbers of platelets are 
decreased. Via signals of the autoregulatory loop TPO serum levels become slightly increased. Thus 
megakaryocyte formation is enhanced to ensure physiologic platelet count. Thereby more virus producing 
cells are available, increasing overall amount of viral particles. 
 
Secondly, hantaviruses can interact with human platelets without productively infecting 
them. Expression of important adhesion molecules is reduced on platelets exposed to 
HTNV, indicating reduced platelet function.  
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4.5 Consequences for the natural host 
Although not analysed yet, it is possible that hantaviruses infect megakaryocytes in the 
bone marrow of their natural reservoir hosts, offering a strategy to establish persistent 
infection. In contrast to humans, the antiviral CTL response is inhibited by regulatory T-
cells in the natural reservoir hosts (Easterbrook et al., 2007; Schountz et al., 2007). This 
could prevent virus elimination resulting in persistent and lifelong infection of cells of 
the megakaryocytic lineage. Intriguingly, megakaryocytes/proplatelets accumulate in 
the lung of humans and rodents (Bozza et al., 2009). Thus infected cells from the bone 
marrow could transport the virus to the lung. In accordance with this view, hantavirus 
RNA has been detected in the lungs of reservoir hosts during persistent infection 
(Botten et al., 2003; Botten et al., 2002; Lee et al., 1986). Increasing platelet demand 
after wounding leads to increased megakaryocyte formation in the bone marrow 
(Deutsch & Tomer, 2006) enlarging the pool of cells, which produce hantaviral virions. 
Such a mechanism could increase the virus load in the blood of wounded animals and 
thus the likelihood for virus transmission. In line with this notion aggressive behaviour 
and wounding correlate with virus transmission (Easterbrook et al., 2007; Escutenaire et 
al., 2002; Glass et al., 1988). Future studies have to clarify whether primary 
megakaryocytes are infected in the natural reservoir host and contribute to persistent 
infection. 
 
4.6 Lymphocytes and monocytes 
A key finding in hantavirus infection is a strong antiviral immune response (Maes et al., 
2004; Schonrich et al., 2008). Analysis of lymphocytes after infection with HTNV in 
vitro showed a strong upregulation of activation marker CD69 on respective cells. CD69 
is involved in lymphocyte proliferation and functions as a signal-transmitting receptor. 
This indicates that HTNV triggers strong lymphocyte activation making them potent 
effector cells. Furthermore, we could show that HTNV prevents apoptosis in monocytes 
isolated from healthy human donors as compared to mock-infected monocytes 
(Schonrich et al., 2008). Most importantly, these HTNV-infected monocytes developed 
into DC-like cells. Similar results were found by other researchers (Markotic et al., 
2007). Monocytes can differentiate into DC like cells after stimulation with IFN-α and 
GM-CSF (Mohty et al., 2003). This suggests that expression of these cytokines is 
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induced in HTNV-infected monocytes, indicating that HTNV triggers an innate immune 
response in human monocytes. It is possible that these DC-like cells also contribute to 
viral dissemination as suggested for immature dendritic cells (Raftery et al., 2002). 
These HTNV-infected DC-like cells could play a role in inducing a dysregulated 
antiviral immune-response. Moreover, the unusual strong and longlasting T-cell memory 
described previously for patients infected many years ago with PUUV (Van Epps et al., 
2002), could also be in part due to development of DC-like antigen-presenting cells. 
Finally, hantavirus-infected immune cells could activate uninfected bystander through 
secretion of cytokines. In line with this notion lies the observation that in infected 
patient’s serum levels of TNF-α (tumor necrosis factor-α) , IFN-γ, IL-6, IL-2 and IL-10 
were elevated (Linderholm et al., 1996; McCaughey & Hart, 2000; Zaki et al., 1995). 
Altogether, these results support the concept of immunopathogenesis during hantavirus 
infection. 
 
4.7 Hantavirus-associated immunopathogenesis 
In conclusion, the results of this thesis strongly support the hypothesis of virus-induced 
immunopathogenesis in humans (figure 38). In the human host hantaviral virions are 
taken up via aerosols. Thus, the lung is the first site of infection. Several cell types that 
are found in the lung are susceptible to hantavirus infection: endothelial cells, dendritic 
cells, monocytes and megakaryocytes, These cells could serve as Trojan horses that 
disseminate the virus in the organism. As in humans no inhibitory T-reg cells are 
induced by hantaviruses, activation of the immune system is not suppressed. 
Subsequently, a strong cytotoxic antiviral immune response develops, characterized by 
release of cytokines, differentiation of infected monocytes into DC-like cells, dendritic 
cell maturation, activation of lymphocytes and CTLs. The latter could attack infected 
cells thereby destroying the endothelial cells and megakaryocytes, which leads to 
thrombocytopenia. Furthermore, the coagulation ability of platelets may be diminished. 
As not enough functional platelets are available the lesions in the damaged endothelial 
barrier cannot be sealed, and haemorrhages develop.  
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Figure 38: Expanded working hypothesis of antiviral immunopathogenesis in humans.  
Next to the dendritic cells in the lung megakaryocytic cells can be infected. Thus these cells are becoming 
targets for CTLs. Once megakaryocytes are attracted by cytotoxic T-cells no more platelets can be formed 
leading to thrombocytopenia. As less platelets are available, lesions in the endothelial barrier cannot be 
fixed anymore, leading to serious haemorrhages. 
 
4.8 Outlook 
For the first time we showed that pathogenic, but not apathogenic hantaviruses interact 
with cells of the haemostatic system. We infected human megakaryocytes with HTNV 
making those cells targets for the immune system and we demonstrated that platelets 
and pathogenic hantaviruses interact, resulting in decreased expression of surface 
proteins essential for platelet function. Moreover we showed strong activation of human 
lymphocytes and differentiation of monocytes into DC-like cells after infection strongly 
supporting the concept of hantavirus-associated immunopathogenesis.  
Further research in this field should concentrate on studies to establish a suitable 
animal model to clarify whether the concept of hantavirus-induced immunopathogenesis 
holds true or whether not yet defined direct viral effects are decisive for the 
development of human disease. Along this line humanized mice that are not only 
equipped with a human immune system but also generate human platelets from human 
megakaryocytes, could be infected with pathogenic hantaviruses. In this way one could 
test whether the antiviral immune response is indeed responsible for hantavirus-induced 
 80 
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acute thrombocytopenia in vivo. With this approach, it could also be clarified whether 
pathogenic hantaviruses affect the clotting ability of platelets. Another interesting 
question will be to investigate the differences between HTNV and other pathogenic 
hantaviruses in megakaryocytic cell lines and humanized mice. Finally, we may not 
forget to study the role of megakaryocytes and platelets in the natural host, where the 
immune response against hantaviruses is downregulated by regulatory T-cells. This 
suggests that infection of megakaryocytes could contribute to lifelong persistence in the 
natural host.  
 All these questions show the urgent need for a suitable animal disease model of 
hantavirus infection. This would strongly facilitate basic research and enable us to 
understand the precise mechanisms underlying hantavirus-associated human disease. 
Based on this knowledge it will be possible to design effective therapies that help 
patients suffering from NE, HFRS or HCPS. 
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